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ABSTRACT 
 
Drosophila Raf (D-Raf) the Drosophila orthologue of the potentially oncogenic Human 
B-Raf. This was established by domain analysis and sequence alignment. D-Raf is the 
only Raf homolog in Drosophila, however it may have two splice variants, a short 
(isoform A) and a long one (isoform B). In this work protocols for expression and 
purification of 117 amino acids long N-terminal segment of D-Raf protein (isoform A), 
both WT and Mutant (T60E; phosphomimetic mutation) are established. In addition these 
protein constructs were biophysically characterized. We can conclude that both WT and 
Mutant can be over-expressed by E. Coli (BL21 strain) in 15N-labeled minimal media, 
the expressed proteins are soluble and can be purified in SEC buffer at pH 6.0. Thrombin 
cleavage conditions were optimized to avoid “over-cleavage”. This result was monitored 
by 5 amino acid N-terminal sequencing, mass spectroscopy and SDS-PAGE 
electrophoresis. An attempt to purify the 160 amino acids (aa) D-Raf (isoform B) N-
terminal segment failed for the protein construct aggregates and precipitates both at pH 
7.4 and pH 6.0. Four liters of bacterial culture in minimal media yielded 0.5 ml NMR 
sample of ~675 micro-Molar 117 aa WT D-Raf (isoform A). NMR spectral 
characterization in a 700 MHz magnet employing three experiments (2D 1H,15N-HSQC, 
3D 1H,15N-TOCSY-HSQC and 3D 1H,15N-NOESY-HSQC), and circular dichroism 
spectroscopy (190-260 nm) indicated that the highly acidic (pI=4.72, carrying negative 
electrical charge of -12) and highly skewed in amino acid content (much more Gln, Glu 
and Leu than average) is folded and is characterized by a helical secondary structure. 
This conclusion was bolstered by the predictions of proteomics tools such as SMART 
and GOR.  Relatively high chemical shift degeneracy is expected and observed. It was 
possible to find several unique couples of amino acids along the sequence. This 
establishes a basis for future total assignment and determination of the protein structure.     
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CHAPTER 1. INTRODUCTION 
 
D-Raf  
The first raf gene was found 24 years ago and characterized as viral oncogene v-raf. 
Normal (proto-oncogenic) cellular homologs of v-raf are conserved components of 
multi-cellular eukaryotic genomes which when mutated become oncogenes. In humans, 
three serine/threonine kinases v-raf analogs are known: A-, B-, and C-raf. These genes 
encode proteins that share conserved regions CR1, CR2 and CR3. Where, CR1, that 
contains the Ras-binding domain and the cysteine-rich domain, and CR2, a Ser/Thr rich 
region, are situated in the N-terminal half of the protein. CR3, which includes the 
catalytic kinase domain, resides in the C-terminus. Mutations in the B-raf gene are found 
in several types of cancer and Raf kinases are targets for anticancer drug development. 
Raf proteins take part in a protein kinase cascade, the RAS/RAF/MEK/MAPK pathway, 
which is involved in development, cell growth and differentiation. This signaling 
cascade has been evolutionarily well-conserved from invertebrates to mammals. 
 
Drosophila has one raf gene. Based on its primary structure, the Drosophila Raf (D-Raf) 
protein is more similar (sequence-wise; E value = 6e-163) to B-Raf than either A-Raf or 
C-Raf. D-Raf appears to be a B-Raf ortholog based on its extended N-terminus and 
putative in-vivo phosphoryation sites. D-Raf has two acidic Glu residues (E420, E421) 
that correspond to residues D447, D448 within the N-region of B-Raf [5]. D-Raf and B-
Raf also share parallels in their modes of regulation. Rap1 can activate both B-Raf and D-
Raf [5]. In addition, both are regulated by phosphorylation. 
 
Comparison of predicted protein sequences of D-Raf cDNAs available in databases 
indicated that D-Raf might undergo differential splicing in the 5’ end, giving rise to two 
D-Raf mRNA variants encoding two protein isoforms. D-Raf isoform B (782 residues) 
includes a 43 amino acid segment within the N-terminal region that is not represented in 
D-Raf isoform A (739 residues). Amino acid residues 18-77 of D-Raf isoform A are 
conserved in B-Raf orthologs from other organisms [5]. In this study, we focused on a 
117 aa N-terminal segment of D-Raf isoform A, the short splice variant. 
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Recent work in Ambrosio's lab shows that the N-terminus of D-Raf participates in several 
signal transduction processes (EGFR, Torso, and Sevenless) [5]. In that study, a 166 aa 
long N-terminal segment of D-Raf isoform B, preceded by a heat-shock promoter, was 
over-expressed in Drosophila eggs [5]. 
 
The RAS/RAF/MEK/MAPK pathway 
The MAPK pathway is a signal transduction pathway that couples intracellular 
responses to binding of growth factors to cell surface receptors. The pathway is very 
complex and includes many protein components. The basic pathway shown in Figure 1.1 
and described below includes the major components of the pathway. Activation of this 
pathway promotes cell division. 
 
Receptor-linked tyrosine kinases such as the epidermal growth factor receptor (EGFR) 
are activated by extracellular ligands. Binding of epidermal growth factor (EGF) to the 
EGFR activates the tyrosine kinase activity of the cytoplasmic domain of the receptor 
and EGFR becomes phosphorylated on tyrosines. Docking proteins such as GRB2 
contain SH2 domains that subsequently bind to the phosphotyrosines of the activated 
receptor. Then GRB2 binds to the guanine nucleotide exchange factor SOS by way of its 
SH3 domain. When the GRB2-SOS complex is docked at phosphorylated EGFR, SOS 
becomes activated and in turn binds to Ras. SOS promotes the removal of GDP from 
Ras. Ras can then bind GTP and become active. 
 
C-Raf was shown to bind efficiently to Ras only when Ras is bound to GTP, not GDP. 
Activated Ras activates the protein kinase of Raf, a Ser/Thr-selective protein kinase. Raf 
phosphorylates and activates MEK, another Ser/Thr kinase. MEK phosphorylates and 
activates mitogen-activated protein kinase (MAPK). A mitogen is a chemical, usually 
some form of a protein that encourages a cell to commence cell division, triggering 
mitosis. Mitogens trigger signal transduction pathways in which mitogen-activated 
protein kinase is involved, leading to mitosis. 
 
Technically, Raf, MEK and MAPK are all mitogen-activated kinases. The series of 
kinases from Raf to MEK to MAPK is an example of a protein kinase cascade. Such 
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series of kinases provide opportunities for feedback regulation and signal amplification. 
Three of the many proteins that are phosphorylated by MAPK are shown in the Figure 
1.1. One effect of MAPK activation is to alter the translation of mRNA to proteins. 
MAPK phosphorylates 40S ribosomal protein S6 kinase (Rsk). This activates Rsk which 
in turn phosphorylates ribosomal protein S6. In addition, MAPK directly regulates the 
activities of several transcription factors including C-Myc and indirectly regulates the 
activity of CREB via phosphorylation of the MNK kinase. CREB regulates the 
transcription of the fos gene. By altering the levels and activities of transcription factors, 
MAPK leads to altered transcription of genes that are important for the cell cycle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: The RAS/RAF/MEK/MAPK signaling pathway [1,2,3,4]
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CHAPTER 2. PROTEOMICS ANALYSIS 
 
Proteomics analysis allows one to glean information about the protein fragment one 
chooses to work with. Domain analysis using the ScanProsite tool [6, 7, 8], and 
biophysical characterization, using ProtParam tool [11, 12], of full-length human B-Raf 
(Table 2.1) and full-length Drosophila D-Raf (Table 2.2) show that the two proteins 
contain nearly the same domain architecture, the pattern of electrical charge of each 
segment is also similar. Specifically, the N-terminal domains are negatively charged and 
the kinase domains are positively charged. This similarity between B-Raf and D-Raf 
strengthened our determination to biophysically characterize the N-terminal segment of 
D-Raf.  
Subsequently, the 117 aa D-Raf WT N-terminal segment sequence was fed into 
ProtParam [11, 12] which gave us information about: total molecular weight, pI, and 
extinction coefficient that helped us in the protein purification step (Table 2.3). In 
addition, ProtParam gave the amino acid composition of our construct and indicated that 
the amino acid content is highly skewed toward Gln, Glu, and Leu (Table 2.4). 
SMART [14, 15] and GOR [16, 17], secondary structure prediction tools (Table 2.5 and 
Figure 2.2), bolstered our experimental findings from Circular Dichroism spectroscopy 
(Chapter 4) that the protein construct has a high content of helical structure. This fact is 
predicted to make NMR spectral assignment procedure relatively harder due to 
degeneracy of the chemical shifts (because most of the sequence assumes the same 
secondary structure most aa would experience similar chemical environment that would 
induce a similar chemical shift).  
In the early stage of protein expression & purification we noticed that the protein fusion-
construct was cleaved at more than one cleavage point. This 'over-cleavage' at moderate 
amounts of Thrombin arose from a non-canonical cleavage site in our construct. This 
fact required us to use much lower amount of Thrombin and to shorten the cleavage 
reaction (some fusion-protein remained). Interestingly, the PeptideCutter tool [19, 20] 
did not predict this non-canonical site. 
We also studied hydropathy plots based on the Kyte-Doolittle method [22, 23]. These 
strengthened our early observation about the highly acidic and hydrophilic nature of the 
117 aa D-Raf (isoform A) N-terminal segment. No hydrophobic stretch is predicted.  
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# aa seq #  B-Raf    sequence  Domain -\+ 
total 
charge 
pI 
108 1-108 
MAALSGGGGGGAEPGQALFNGDMEPEAGAGRPAASAA
DPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYL
EAYEEYTSKLDALQQREQQLLESLGNGTDF 
27 109-135 SVSSSASMDTVTSSSSSSLSVLPSSLS
19 135-153 VFQNPTDVARSNPKSPQK
N-Terminal 
segment: 
NN+Serine 
rich region+ 
CN 
20\9 -11 4.41 
73 154-226 
PIVRVFLPNKQRTVVPARCGVTVRDSLKKALMMRGLIP
ECCAVYRIQDGEKKPIGWDTDISWLTGEELHVEVL 
RBD (Ras 
Binding 
Domain) 
9\11 2 8.71 
7 227-232 ENVPLT linker 1\0 -1 4 
47 233 - 279 THNFVRKTFFTLAFCDFCRKLLFQGFRCQTCGYKFHQR
CSTEVPLMC 
ZF_DAG_PE_
2/1  
2\7 5 9.15 
176 280-455 
VNYDQLDLLFVSKFFEHHPIPQEEASLAETALTSGSSPSA
PASDSIGPQILTSPSPSKSIPIPQPFRPADEDHRNQFGQRD
RSSSAPNVHINTIEPVNIDDLIRDQGFRGDGGSTTGLSAT
PPASLPGSLTNVKALQKSPGPQRERKSSSSSEDRNRMKT
LGRRDSSDDWEIPDGQ 
linker 24\18 -6 5.17 
261 456-716 
ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQ
QLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQW
CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK
SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF
EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL
MTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA
MKRLMAECLKKKRDERPLFPQILASIELL 
Ser/Thr Protein 
Kinase 
Domain 
22\32 10 9.5 
49 717-765 ARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQA
GGYGAFPVH 
linker 3\5 2 9.11 
 
Table 2.1: Domain  sequence analysis and characteristic biophysical parameters WT B-
Raf (Human Raf isoform). '# aa', number of amino acids in each segment; 'seq #', order 
of the aa in the sequence. Domain identification was done automatically using the 
ScanProsite tool [6, 7, 8]. Biophysical parameters, such as pI and number of electrically 
charged aa was calculated by ProtParam tool [11, 12] for each segment. '-\+', number of 
negative and positive electrical charge, respectively.  'NN', N-terminus of the N-terminal 
segment. 'CN', C-terminus of the N-terminal segment. 
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# aa seq # D-Raf   sequence Domain -\+ 
total 
charge 
pI 
79 1-79 
MSSESSTEGDSDLYDPLAEELHNVQLVKHVTRENIDALN
AKFANLQEPPAMYLIEYQELTSKLHELEAKEQELMERLN
SQD 
34 80-113 QQEDSSLVERFKEQPHYQNQTQILQQQRQLAR 
N-Terminal 
segment:NN+ 
Gln-rich 
region (low 
score) 
22\10 -12 4.59 
27 114-140 VHHGNDLTDSLGSQPGSQCGTLTRQPK linker 2\2 - 6.88 
72 141-212 ILLRAHLPNQQRTSVEVISGVRLCDALMKALKLRQLTPD
MCEVSTTHSGRHIIPWHTDIGTLHVEEIFVRLL 
RBD (Ras 
Binding 
Domain) 
7\8 1 8.09 
10 213-222 DKFPIRTHIK linker 1\3 2 9.99 
49 223-271 HQIIRKTFFSLVFCEGCRRLLFTGFYCSQCNFRFHQRCAN
RVPMLCQPF 
ZF_DAG_PE_
2/1 
1\7 6 9.49 
31 272-302 PMDSYYQLLLAENPDNGVGFPGRGTAVRFNM 
25 303-327 SSRSRSRRCSSSGSSSSSKPPSSSS 
101 328-428 
GNHRQGRPPRISQDDRSNSAPNVCINNIRSVTSEVQRSLI
MQARPPLPHPCTDHSNSTQASPTSTLKHNRPRARSADES
NKNLLLRDAKSSEENWNILAEE 
linker:  
N+Ser-rich 
region+C 
14\21 7 10.3 
258 429-686 
ILIGPRIGSGSFGTVYRAHWHGPVAVKTLNVKTPSPAQL
QAFKNEVAMLKKTRHCNILLFMGCVSKPSLAIVTQWCE
GSSLYKHVHVSETKFKLNTLIDIGRQVAQGMDYLHAKNI
IHRDLKSNNIFLHEDLSVKIGDFGLATAKTRWSGEKQAN
QPTGSILWMAPEVIRMQELNPYSFQSDVYAFGIVMYELL
AECLPYGHISNKDQILFMVGRGLLRPDMSQVRSDAPQAL
KRLAEDCIKYTPKDRPLFRPLLNML 
Ser/Thr 
Protein Kinase 
Domain 
21\31 10 9.42 
53 687-739 ENMLRTLPKIHRSASEPNLTQSQLQNDEFLYLPSPKTPVN
FNNFQFFGSAGNI 
linker 4\4 - 6.86 
 
Table 2.2: Domain  sequence analysis and characteristic biophysical parameters WT D-
Raf (Drosophila isoform A Raf ortholog of human B-Raf). '# aa', number of amino acids 
in each segment; 'seq #', order of the aa in the sequence. Domain identification was done 
automatically using the ScanProsite tool [6, 7, 8]. Biophysical parameters, such as pI and 
number of electrically charged aa was calculated by ProtParam tool [11, 12] for each 
segment. '-\+', number of negative and positive electrical charge, respectively.  
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Conclusions about the Human B-RAF and Drosophila D-Raf sequences 
1. The pattern of high electric negative charge (-11\-12) on the N-terminal segment and 
high positive charge on (+10) the kinase domain is observed both in B-Raf and D-
Raf. 
2. The other segments in the two sequences have a similar electric charge distribution, 
except the opposite electrical charge on the linker preceding the kinase domain: +7 in 
D-Raf whereas it is -6 in B-Raf. 
3. The Serine-rich segments: in B-Raf it occurs in the N-terminal portion, whereas, in 
D-Raf it is included in the linker preceding the kinase domain. 
4. The N-terminal segment in D-Raf includes a Glutamine-rich segment.  
 
Characterization of the different segments and domains: 
Glutamine-rich segment 
Gln/Asn-rich domains are ubiquitous, modular, associated with a variety of types of 
proteins, and have been evolutionarily conserved in a number of these proteins. This 
conservation suggests an independent functional role for these domains. Growing 
evidence suggests that Gln/Asn-rich domains function as mediators of specific protein–
protein interactions. Max Perutz has suggested that Gln/Asn-rich regions (and possibly 
regions rich in other polar residues) might behave as modular mediators of protein–
protein interactions termed “polar zippers” because of the capacity of their side chains to 
form hydrogen bond networks [9, 10].   
 
Serine-rich segment 
Possible functions: spacer, protein stability contribution, phosphorylation site that 
modulates kinase domain function or modulates a protein binding interaction. 
 
Zinc finger Phorbol-ester/DAG-type signature and profile 
Di-acyl-glycerol (DAG) is an important second messenger. Phorbol esters (PE) are 
analogues of DAG and potent tumor promoters that cause a variety of physiological 
changes when administered to both cell- and tissue cultures. DAG activates a family of 
serine/threonine protein kinases [6], collectively known as protein kinase C (PKC). 
Phorbol esters can directly stimulate PKC. The N-terminal region of PKC, known as C1, 
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has been shown to bind PE and DAG in a phospholipid and zinc-dependent fashion. The 
C1 region contains one or two copies (depending on the isozyme of PKC) of a cysteine-
rich domain about 50 aa long and essential for DAG/PE-binding. The DAG/PE-binding 
domain binds two zinc ions [6]; the ligands of these metal ions are probably the six 
cysteines and two histidines that are conserved in this domain. This site in B-Raf binds 
ceramide [5]. 
 
Ras Binding Domain (RBD) 
Ras and heterotrimeric G protein α subunit are signal-transducing GTPases that cycle 
between inactive GDP-bound and active GTP-bound forms. The activities of these GTP-
ases are regulated in part by GTPase-activating proteins (GAPs) that stimulate 
hydrolysis of GTP, and guanine nucleotide exchange factors (GEFs) that stimulate GDP 
release. Ras and G protein alpha GTPases are prolific signaling molecules interacting 
with a spectrum of effector molecules and acting through more than one signaling 
pathway. The Ras-binding domain (RBD) is an independent domain of about 75 aa, 
which is sufficient for GTP-dependent binding of Ras and other G protein alpha 
GTPases [6]. Structurally, the RBD domain of Raf-1 consists of a five-stranded betta-
sheet with an interrupted alpha-helix and two additional small alpha-helices [6]. The 
structure of the RBD domain belongs to the ubiquitin alpha/betta roll super-fold. The 
major interaction between Ras and Raf-1 RBD domain occurs between two antiparallel 
betta-strands [6]. 
 
Serine/Threonine Protein Kinase Domain 
Eukaryotic protein kinases are enzymes that belong to a very extensive family of 
proteins which share a conserved catalytic core common to both serine/threonine and 
tyrosine protein kinases [6]. There are a number of conserved regions in the catalytic 
domain of protein kinases. Two of these regions were selected to build signature 
patterns. The first region, which is located in the N-terminal extremity of the catalytic 
domain, is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has 
been shown to be involved in ATP binding. The second region, which is located in the 
central part of the catalytic domain, contains a conserved Asp residue important for the 
enzymatic catalytic activity[6].
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ProtParam analysis  
N-terminal segment of D-Raf (isoform A) WT 117 aa, the sequence of the construct we 
used in this research is shown in Figure 2.1: 
 
                    10                        20                         30                        40                       50           
GSSESSTEGD  SDLYDPLAEE  LHNVQLVKHV   TRENIDALNA  KFANLQEPPA  
                     60                       70                         80                       90                       100         
MYLIEYQELT  SKLHELEAKE  QELMERLNSQ  DQQEDSSLVE  RFKEQPHYQN 
                    110 
QTQILQQQRQ  LARIHRD  
 
Figure 2.1: Sequence of N-terminal segment of D-Raf (isoform A) WT 117aa.  
ProtParam [11, 12] is a web-based bioinformatics research tool that calculates basic 
biophysical parameters for an any input sequence. We gave it as an input the sequence in 
Figure 2.1, the results are tabulated in Table 2.3: 
117 aa D-Raf (Isoform A) WT 
Number of amino acids in the sequence 117 
Molecular Weight (theoretical) 13.704 kDa 
Theoretical pI 4.72 
Extinction coefficient [280 nm] 5960 [M-1cm-1]
Total number of negatively charged residues (Asp + Glu) 23 
Total number of positively charged residues (Arg + Lys) 11 
 
Table 2.3: ProtParam analysis [11, 12] results for 117 aa D-Raf (Isoform A; WT) N-
terminal segment. 
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Amino acid composition of 117 aa WT D-Raf (isoform A) N-terminal segment 
Amino 
acid 
type 
Number of  
occurrences in the 
sequence 
Frequency in this 
construct (%) [11, 
12] 
Frequency in 
proteins in 
general (%) [13] 
Relative frequency (the difference between the 
two preceding columns) 
Low/-/High 
Ala (A) 7 6.0 7.4 - 9.6 - 
Arg (R) 6 5.1 3.4 - 5.7 - 
Asn (N) 6 5.1 4.1 - 4.6 - 
Asp (D) 7 6.0 5.0 - 5.9 - 
Cys (C) 0 0.0 1.5 - 3.3 L 
Gln (Q) 15 12.8 3.2 - 4.0 H 
Glu (E) 16 13.7 5.3 - 6.3 H 
Gly (G) 2 1.7 6.7 - 9.0 L 
His (H) 5 4.3 1.9 - 3.4 - 
Ile (I) 4 3.4 3.5 - 5.7 - 
Leu (L) 15 12.8 7.6 - 9.7 H 
Lys (K) 5 4.3 5.4 - 8.5 - 
Met (M) 2 1.7 1.2 - 2.4 - 
Phe (F) 2 1.7 3.5 - 4.5 L 
Pro (P) 4 3.4 4.1 - 5.2 - 
Ser (S) 9 7.7 5.7 - 8.1 - 
Thr (T) 4 3.4 5.5 - 6.3 L 
Trp (W) 0 0.0 1.1 - 1.6 L 
Tyr (Y) 4 3.4 2.9 - 3.8 - 
Val (V) 4 3.4 6.1 - 7.8 L 
Table 2.4: Amino acid composition of the 117 aa D-Raf (isoform A) WT N-terminal 
segment. The first column (right most) list the names of the 20 standard amino acids 
(three- and one-letter abbreviations). The second column lists the number of aa, of each 
type, occurring in our construct. The third column lists percentages of the number of aa 
relative to the total number of aa, in our construct (i.e., 117 aa). Fourth column lists the 
average frequency of the different aa in proteins in general (vertebrate and bacterial) [13]. 
Left most column indicates if the the frequency of aa in our construct is significantly 
different (lower or higher) relative to their respective frequency in proteins in general.      
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Conclusions drawn from Table 2.4 
1. The sequence does not include tryptophane (W): the lack of this aa explains the 
relatively low value of the extinction coefficient (both theoretical and that actually 
measured). Extinction coefficient of a protein is calculated using the formula:   
E(Protein) = Number(Tyr)*Ext(Tyr) + Number(Trp)*Ext(Trp) + 
Number(Cystine)*Ext(Cystine); whereas for proteins in water measured at 280 nm: 
Ext(Tyr) = 1490, Ext(Trp) = 5500, Ext(Cystine) = 125. Note that the specific 
extinction coefficient of Trp is the highest, and that our 117 aa D-Raf (isoform A) N-
terminal sequence contains only four tyrosines.   
2. The sequence has a high and negative electrical charge (-12): the total electrical charge 
is determined by the number of Asp & Glu (=23) relative to the number of Arg & Lys 
(=11) in the sequence. This difference explains the highly acidic nature of the N-
terminal protein segment and its low pI (=4.72). To avoid precipitation of the protein  
during the purification process we used phosphate buffer at pH 6.0 rather than 
phosphate buffer at pH 7.4 ; we preferred not to use a buffer with lower pH than 6.0 
since we wanted to simulate in-vivo conditions (i.e. physiological) as possible and to 
avoid artifacts in the NMR signal such as chemical shifts due to low pH. Indeed, GST 
does not stabilize the N-terminal segment enough relative to its stabilization in the 
whole D-Raf protein (i.e. full length) in-vivo.  
3. Amino acid content in our sequence is skewed: Gln, Glu, and Leu are much more 
frequent (39%) in the N-terminal segment relative to their frequency in an expansive 
database of non-redundant proteins (18%) [13]. On the other hand, Gly, Trp, Cys, Val, 
Thr, and Phe appear (10%) in relatively lower frequency of the expected 28%. The 
comparison should be only qualitative as the database is not based exclusively on 
Drosophila melanogaster proteins. Spectral overlap of certain aa NMR chemical shifts 
is expected, due to high repetition of these specific aa in the sequence. Moreover, 
TOCSY interpretation would be relatively difficult since we have only few signature 
patterns such as those from Gly (α protons), Val, and Thr (β&γ aliphatic protons). 
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Prediction of secondary structure 
We used two web-based tools to predict the secondary structure of the N-terminal 
segment: 
1) SMART (Simple Modular Architecture Research Tool) [14, 15]: allows the 
identification and annotation of genetically mobile domains and the analysis of domain 
architectures. More than 500 domain families found in signaling, extracellular and 
chromatin-associated proteins are detectable. These domains are extensively annotated 
with respect to phyletic distributions, functional class, tertiary structures and functionally 
important residues. Each domain found in a non-redundant protein database as well as 
search parameters and taxonomic information are stored in a relational database system. 
User interfaces to this database allow searches for proteins containing specific 
combinations of domains. 
This program predicted two features (Table 2.5). First, a continuous long segment that 
spans ~50% of the sequence and assumes a secondary structure of intimately-associated 
bundles of long alpha-helices. Second, two segments, flanking the helices bundle that are 
intrinsically disordered. Beta-sheets are not predicted. 
secondary-structure type Sequence begins at 
aa # 
Sequence ends at    
aa # 
intrinsic disorder 1 25 
coiled-coil 26 85 
intrinsic disorder [low-complexity, Gln-
rich] 
86 117 
 
Table 2.5: SMART [14, 15] predictions regarding secondary structure of WT 117 aa D-
Raf (isoform A) N-terminal segment. 
 
2) GOR (Garnier-Osguthorpe-Robson) method [16, 17]: uses both information theory 
and Bayesian statistics for predicting the secondary structure of proteins. Includes 
large databases with detailed statistics, which account not only for amino acid 
composition, but also for amino acid pairs and triplets. Includes evolutionary 
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information using PSI-BLAST to increase the information content for improved 
discrimination among secondary structures. The prediction accuracy reaches 73.5% 
based on a database of 513 sequentially non-redundant domains. As can be seen in 
Figure 2.2, GOR predicts that ~60% of the N-terminal segment is in helical 
conformation; the rest of the sequence is predicted to assume random-coil 
conformation. Also here, no beta-strands are predicted.  
 
                      10                             20                               30                               40                                  50           
 GSSESSTEGD       SDLYDPLAEE      LHNVQLVKHV         TRENIDALNA            KFANLQEPPA 
CCCCCCCCCC     CCCCCCCCCH      HHHHHHHHHH       HHHHHHHHHH          HCCCCCCCCC            
                       60                                70                              80                             90                              100                          
 MYLIEYQELT         SKLHELEAKE       QELMERLNSQ      DQQEDSSLVE         RFKEQPHYQN 
HHHHHHHHHH     HHHHHHHHHH     HHHHHHHCCC     CCCCCCCHHH        HHHCCCCCHH  
                      110 
 QTQILQQQRQ        LARIHRD 
HHHHHHHHHH     HHCCCCC 
 
Figure 2.2: GOR [16, 17] predictions regarding secondary structure of WT 117 aa D-Raf 
(isoform A) N-terminal segment. 'C', random coil (blue background); 'H', Helix (red 
background). 
 
 
Conclusions regarding predicted secondary structure 
 
1) The N-terminal segment of 117 aa D-Raf (isoform A) contains several helices 
connected by short coils, but no beta-sheets. 
 
2) There are some differences between the predictions of SMART and GOR: helical 
content (50% vs. 60%), and location of the helices (continuous according to SMART 
vs. dispersed along the sequence according to GOR). A difference is well anticipated 
because the prediction accuracy falls short of 100% and the algorithms used are 
different. These results should be evaluated only qualitatively. 
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Predicted peptide cleavage sites by PeptideCutter 
We expressed the D-Raf (isoform A) N-terminal segment 117 aa as a fusion protein, for 
purification purposes fused to GST. To separate our 117 aa protein from GST we 
cleaved the peptide backbone that connects the two in an engineered Thrombin cleavage 
site between the two segments. Thrombin canonical cleavage site is LVPR/GS, the 
fraction slash indicates the specific peptide bond which is cleaved. We obviously wanted 
the protease, i.e. Thrombin, to cleave only at this site. Cleavage in any other site would 
lower the yield of the protein after purification and introduce oligopeptide impurities 
into the protein solution leading to artifact signals in NMR analysis. Therefore, we 
checked if Thrombin has any other predicted cleavage sites along the sequence of D-Raf 
(isoform A) N-terminal segment 117 aa. We used the web-based tool PeptideCutter [19, 
20] for this purpose.  
Thrombin preferentially cleaves at Arg in position P1 (see Figure 2.3). The natural 
substrate of Thrombin is Fibrinogen. Optimum cleavage sites are when Arg is in 
position P1 and Gly is in positions P2 and P1'. Likewise, when hydrophobic residues are 
found in position P4 and position P3, Pro in position P2, Arg in position P1, and non-
acidic amino-acids in position P1' and position P2'. A very important residue for its 
natural substrate Fibrinogen is an Asp in P10 (but this site is neglected in the 
PeptideCutter program).    
 Substrate:        Pn.........P4---P3---P2---P1-/-P1`---P2`---P3`---P4`.........Pm` 
  Protease:                     S4---S3---S2---S1---S1`---S2`---S3`---S4` 
Figure 2.3: Schematic representation of enzyme-substrate complex with eight binding 
sites. Positions Pn to Pm` in the substrate are counted from the bond between P1 and 
p1`, where cleavage occurs (fraction slash). 
 
PeptideCutter prediction [19, 20]:No other cleavage sites, i.e. other than the engineered 
one at the beginning of the sequence, were predicted for D-Raf (isoform A) N-terminal 
segment 117 aa. This result should be interpreted with some caution, as proteases may 
also cleave in non-canonical sites, depending on the specific conditions in the protein 
solution: pH, temperature, enzyme-substrate ratio, and the time allotted for the cleavage 
reaction to proceed.
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Hydropathy plot by Kyte-Doolittle method 
 
Kyte-Doolittle hydropathy plots [22, 23] give information about the hydrophobic nature 
of the residues along a protein backbone. A hydropathy plot can indicate: (i) potential 
transmembrane segments, or (ii) surface regions in proteins. In this method each amino 
acid is given a hydrophobicity score between +4.5 and -4.5. A score of +4.5 is the most 
hydrophobic (Isoleucine) and a score of -4.5 (Arginine) is the most hydrophilic. Then, a 
window size is set. The window size is the number of aa whose hydrophobicity scores 
will be averaged and assigned to the first amino acid in the window. Computer program 
moves down one amino acid along the sequence and calculates the average of all the 
hydrophobicity scores in the new window. This pattern continues to the end of the 
protein, computing the average score for each window and assigning it to the first aa in 
the window. The averages are then plotted on a graph. The 'y-axis' represents the 
hydrophobicity scores and the 'x-axis' represents the window number. 
 
By varying the parameters of Kyte-Doolittle tests done on proteins whose structure was 
known, Kyte and Doolittle [22, 23] found the parameters that predicted protein structure 
the best: when looking for surface regions in a globular protein, a window size of 9 was 
found to give the best results. Surface regions can be identified as peaks below the mid 
line. When looking for a transmembrane region in a protein, a window size of 19 is 
needed. Transmembrane regions are identified by peaks with scores greater than 1.6 
(this value was determined empirically) using a window size of 19. 
 
The GRAVY score is the average hydropathy score for all the aa in the protein. Integral 
membrane proteins typically have higher GRAVY scores than do globular proteins. 
Though this score, i.e. GRAVY, is another helpful piece of information, it cannot 
reliably predict the structure without the help of hydropathy plots. 
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Figure 2.4:  Window size of 9 aa, Kyte-Doolittle hydropathy plot for the 117 aa D-Raf 
(isoform A) N-terminal construct. Most of the protein (blue line) is hydrophilic, its line 
stays below zero for most of the sequence. The N-terminal and the C-terminal are more 
hydrophilic then the central part (around the 40th aa). The C-terminal has two short 
stretches that are especially hydrophilic (around the 85th and 95th aa). The red line is at 
hydrophobicity score of 1.6 and designates an empirical cutoff value for transmembrane 
segments (relevant for window size of 19 aa).  
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Window size of 19 aa, Kyte-Doolittle hydropathy plot for the 117 aa D-Raf 
(isoform A) N-terminal construct. The construct is not likely to contain any 
transmembrane segment; the protein line (blue) is far from the red line. The red line is at 
hydrophobicity score of 1.6 and designates an empirical cutoff value for transmembrane 
segments of ~19 aa long. 
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CHAPTER 3. PROTEIN EXPRESSION & PURIFICATION  
 
“Test” expression 
Ambrosio's lab supplied two plates (WT and MUTANT) of Escherichia Coli with pGEX 
plasmids. The plasmid in the colonies on the WT plate carried the sequence for the GST 
fused D-Raf (isoform A) N-terminal segment (117 aa). The plasmid in the colonies on the 
MUTANT plate carried the same construct but with the T60E mutation. This mutant is a 
phosphomimic, is conserved in both B-Raf and D-Raf, predicted by the NetPhos 2.0 web-
based proteomics tool to be a phosphorylation site. However, still there is no empirical 
evidence that this site is actually phosphorylated in D-Raf in-vivo or in-vitro. The GST 
protein serves as a tag that allows purification of our protein of interest using an affinity 
column (glutathione-sepharose 4B produced by Amersham Biosciences; see appendix for 
expanded explanation of this gene fusion system). First there was a need to check if the 
proteins were over-expressed in E. Coli strain BL21 (aka DE3), and if they remain in the 
cytosolic compartment or transfered into “inclusion bodies” where they are insoluble. 
Therefore, a colony was picked from each plate and over-night (o/n) cultures were grown 
(37 °C on rotating plate @ 250 rpm) in 5 ml Luria-Bertini broth (LB). The plasmid was 
purified from each bacterial culture using a standard protocol and QIAprep spin miniprep 
kit (QIAGEN). Stocks of competent BL21 bacteria were transformed with the purified 
plasmids and streaked on new plates (containing Ampicillin). After o/n incubation, 
colonies were picked and cultured o/n. 50 ml of “minimal media” (see Appendix for 
formula) were inoculated with the o/n culture and bacteria were incubated on shaker at 37 
°C until the optical density (600 nm) reached between 0.6 to 0.8. When ready, the flasks 
were transferred to a cooled (15 °C) shaker/incubator. After 15 minutes of cooling, the 
bacterial cultures were 'induced' with 50 μl of 1 M IPTG (Iso-propyl betta-D-1-thio-
galacto-pyranoside; this sugar is a master regulator of the lac operon that was engineered 
to contain our gene construct), the culture was incubated (15 °C and shaking) for 24 
hours and a 1 ml sample was taken every 3 to 5 hours. Each collected sample was spun 
down for 5 min at 4000 rpm, the media was then decanted and the bacterial pellet was 
resuspended with 100 μl of “Resuspension buffer” (see Appendix). Quickly after 
resuspension the samples were snap-freezed and stored in a -80 °C freezer on a pre-
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cooled metal plate. The following day  samples were taken out of the freezer and left to 
thaw on the bench for exactly 5 minutes. The thawing action lyses the bacterial cells and 
releases the protein from the cytoplasmic compartment. Samples were then centrifuged 
for 20 minutes in 14000 rpm @ 4 °C cooled mini-centrifuge. The supernatant of each 
sample was transfered to a new Eppendorf micro test-tube (1.7 ml). The remaining pellet 
was resuspended in 101 μl of “Pellet buffer” (see Appendix for formula). The pellets and 
supernatants were run on 12% SDS-PAGE gel. The gels were scanned and are shown in 
Figure 3.1 (WT protein construct) and Figure 3.2 (Mutant protein construct):  
 
 
Figure 3.1: “Test-expression” results for the the 117 aa long D-Raf (isoform A) WT fused 
to GST. The fused protein travels at ~39.7 kDa. GST alone is also over-expressed and 
travels at ~26 kDa. The over-expressed proteins stay in the supernatant (S) fraction which 
means it is soluble, and their quantity grows as time passes (max quantity after 24 hours 
of induction and incubation at 15 °C on shaker, culture grown in minimal media).  Only 
insignificant amount of fused protein appears in the pellet (P), i.e., the insoluble fraction 
which we cannot extract the protein from. 
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Figure 3.2: “Test-expression” results for the the 117 aa long D-Raf (isoform A) 
MUTANT (T60E) fused to GST. The fused protein travels at ~39.7 kDa. GST alone is 
also over-expressed and travels at ~26 kDa. The over-expressed proteins stay in the 
supernatant (S) fraction which means it is soluble, and their quantity grows as time passes 
(max quantity after 24 hours of induction and incubation at 15 °C on shaker, culture 
grown in minimal media). Only insignificant amount of fused protein appears in the 
pellet (P), i.e., the insoluble fraction which we cannot extract the protein from.  
 
Conclusions from the “test-expression” 
Both the WT and Mutant (T60E) 117 aa long D-Raf (isoform A) fusion proteins can be 
over-expressed in minimal media, the produced fusion proteins are soluble and 
accumulate in large quantity.  
 
“Full” expression and purification 
Eight 2 liter flasks (500 ml each) with 15N labeled minimal media (nitrogen isotope of 
relative atomic mass of 15 grams per mol; this is a spin half isotope and therefore NMR 
active). We used labeled Ammonium Chloride as a source for 15N [Cambridge Isotope 
Laboratories, Inc., 15N, 99%, 10 gr bottle]. We expressed only the 117 aa long WT D-
Raf (isoform A), at the same conditions of the “Test expression”, i.e. 15 °C in an 
incubator with a rotating shaker. The bacterial culture was harvested after 24 hours of 
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expression, collected in 50 ml conical tubes, then a dash of lysozyme [SIGMA, 
Lysozyme, from chicken egg white, 44700 units/mg, 5 gr bottle] was added, and the 
tubes were stored at -80 freezer o/n. The following day, the 50 ml conical tubes with the 
frozen cells in them were half thawed in a beaker immersed in a hot-water bath (40 °C). 
We added 120 μl of DNase [SIGMA, D4527-40kU, Deoxyribonuclease I, Type II, from 
Bovine Pancreas] per 35 ml of bacterial slurry. When ¾ thawed 350 μl of 100 mM PMSF 
[Phenyl-methane-sulfonyl fluoride, SIGMA P7626-5 gr] was added per tube. PMSF is a 
serine- and cysteine- protease inhibitor, and used here to inhibit intra-cellular proteases. 
Next, the slurry was poured into special JA-20 rotor centrifuge tubes (they can hold max 
40 ml). The tubes were centrifuged at 16000 rpm (~31000 g) for 1 hour (hr). In a cold-
room, the supernatants were poured into a regenerated glutathione-sepharose column (the 
column funnel can hold up to 500 ml). After full elution, the column was washed with 
200 ml SEC buffer (add 350 μl of PMSF every 90 minutes). Next, the GST and GST-
tagged protein were eluted into an empty 100 ml beaker in two steps (85 ml + 15 ml) 
with 10 mM glutathione in SEC buffer (adjusted to pH 6.0). GST would be isolated from 
the prep in a later stage using size-exclusion column. To get rid of the high concentration 
of glutathione we “buffer-exchanged” using a concentrator (Millipore stirred 
ultrafiltration pressure cell) with YM10 filter membrane (10 kDa cutoff; Ultracel Amicon 
Ultrafiltration Disc). The exchange was done moderately, each time concentrating down 
to about 20 ml and then adding up to full (200 ml) with fresh SEC buffer. Concentrating 
down to less than 10 ml, at this stage, would lead to “protein crash”. In total, ~450 ml 
were filtered out of the concentrator. When transfered into a 50 ml glass beaker, the final 
volume of the protein solution was ~37 ml.       
 
Fusion-protein “Full-cleavage” 
It is preferable to conduct a “Test-cleavage” for each batch of fusion-protein solution 
(i.e., on only 1 ml of protein solution) before conducting the “Full-cleavage” (i.e., on the 
whole ~37 ml of protein-solution) because: (i) solution consistency changes a little with 
every preparation, i.e., fusion protein concentration, salts concentration, glutathione 
concentration, etc. (ii) the protein is sensitive to over-cleavage, and (iii) the activity of 
commercially supplied Thrombin varies from batch to batch. The fusion protein solution 
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was cleaved (Figure 3.3) using 0.008 units of Thrombin per ml of protein solution, (e.g., 
to a 37 ml fusion-protein solution add 296 μl of Thrombin solution; see Appendix for 
preparation of Thrombin solution) on the bench (at RT), for 4.5 [hr]. The 117 aa long WT 
D-Raf (isoform A) and the 117 aa T60E MUTANT D-Raf (isoform A) constructs have 
the same Thrombin-cleavage conditions (data not shown because the gels fractured 
during the gel-drying process). Note in Figure 3.3 that the 117 aa WT D-Raf (isoform A) 
mobility is lower than expected from its molecular weight (13.7 kDa, but looks like 16 
kDa on the gel). Proteins that were not completely denatured and/or highly charged 
proteins, such as the positively-charged Histone and the highly acidic Sigma (net charge -
45), are know to migrate with different mobility as expected from their molecular weight. 
The same is true for post-translationally modified proteins. In the case of Sigma, it is 
known from examination of proteolytic fragments that the anomalous migration is 
primarily due to one segment of the protein that contains 18 acidic residues out of 22. 
Some proteins show either higher or lower mobility. The anomalous migration thus 
appears to be due to high or low charge on the protein. It is commonly thought that these 
factors effect SDS (C12H25NaO4S) binding, and therefore compromise the basic 
assumption of SDS-PAGE electrophoresis: that all proteins have an equal charge density 
due to complete coating of the molecule with SDS. If there are significant regions of the 
protein fragment with low SDS density, the protein may not adopt the extended 
conformation thought to be typical of proteins in SDS. Highly negatively-charged 
proteins, as the 117 aa WT D-Raf (isoform A) N-terminal segment, may repel the 
negatively charged SDS and therefore have lower negative charge density relative to a 
protein with high ratio of hydrophobic amino acids. 
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Figure 3.3: “Test-Cleavage” results for the the 117 aa D-Raf (isoform A) WT segment 
fused to GST. The numbers on the right side of the gel designate the MW in kDa of the 
corresponding marker ladder (M). Time is shown above gel lanes in hours; '0' time is the 
moment of adding the protease. Cleavage was quenched with PMSF exactly after 4.5 hrs. 
It can be seen that the cleavage of the fusion protein was not complete, we chose not to 
proceed cleaving to avoid over-cleavage. The diminishing upper bands (39.7 kDa) are the 
fusion protein. The increasing middle bands (26 kDa) are GST. The lower increasing 
bands are the 117 aa long D-Raf (isoform A) WT (13.7 kDa). Note, the N-terminal 
segment migration is anomalous, it is lower, as if its MW is higher (~16 kDa). This may 
occur because of its high acidity. The shaded lines beneath the three proteins are shadow 
artifacts created during scanning of the gels. We used 0.008 Units of Thrombin per μl of 
fusion-protein @ room temperature.   
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Purification after “Full-cleavage” 
Right after quenching the fusion-protein cleavage process with 350 μl of PMSF the 
solution was poured into a regenerated glutathione-sepharose column (in cold-room). The 
flow-through was collected (contains our protein of interest), the GST clung to the 
column. Subsequently, we washed the column three times, with: 50 ml, 20 ml and 10 ml 
SEC buffer, the washes were collected separately and absorbance was measured. The 10 
ml wash had insignificant absorbance and therefore practically had no protein in it, this 
conclusion was supported by running a gel of the three washes. We mixed the Flow-
through and the two washes (50ml and 20 ml) together and concentrated them, using 
YM3 membrane (3 kDa cutoff), down to ~7 ml in a stirred concentrator in the cold room. 
The protein was collected in a 10 ml glass beaker and load onto a size-exclusion column 
(Amersham Biosciences: Sephacryl S-100 high-resolution gel, cat # 17-0612-01, in XK 
26/100 column, i.e., 26 mm inner diameter and 100 cm long, cat # 19-5203-01, driven by 
peristaltic pump P-1 by Pharmacia Biotech, cat #18-1110-91). The elution through the 
column, in the cold room, takes 19 hrs. The eluted protein solution was dispensed into 
144 x 2 tubes (two racks, 'Back' rack and 'Forward' rack; 13 mm glass tubes) placed in an 
automated fraction collector (ISCO Foxy 200; 4 minutes collection time per tube). The 
117 aa N-terminal segment of D-Raf (isoform A), WT [in a subsequent preparation 
Mutant (T60E)] eluted into 'Back' rack tubes numbered from '4' to '32'. Determining 
which of the tubes contain our protein of interest required measuring the absorbance @ 
280 nm and running 12% SDS-PAGE gels that show pure bands (one band per lane) 
close to the anticipated MW migration length. The tubes with a pure band of 117 aa D-
Raf N-terminal segment were collected and concentrated down to 460 μl in the cold-
room using YM3 (3 kDa cutoff) membrane with stirred concentrator (first use the 50 ml 
concentrator and then the 10 ml one). The concentration of the protein at this stage was ~ 
750 μΜ (starting from eight flaks of 500 ml minimal media bacterial cultures).  
 
Preparation of the NMR sample 
The sample final volume was 500 μl with 10% v/v D2O (deuterated water aka 'heavy 
water' provided by SIGMA: deuterium oxide 99.9%, CAS 7789-20-0), therefore the final 
protein concentration was ~675 μΜ (starting from eight flasks of 500 ml minimal media 
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bacterial cultures). The protein sample was transfered to a Shigemi tube for NMR signal 
measurement (SIGMA: 5 mm diameter, 8 inches length, series 500, D2O matched 
borosilicate glass, cat # Z543349). We added deuterated water to achieve sufficiently 
strong NMR “lock” signal. In order to take a high resolution spectrum, the magnetic field 
has to be stable and homogeneous. If the magnetic field strength changes during the 
course of the acquisition, the signals will appear broadened and the spectrum will have 
poor resolution. To keep the field stable, the spectrometer has a mechanism that corrects 
the field's drift as it occurs (“the lock system”). The drift is measured using the 
absorption frequency of the solvent's deuterium resonance (the lock signal). As this 
frequency changes due to a change in the field, an electric current is applied to a coil in 
the magnet that increases or decreases the field's strength to keep the signal in the same 
position and the field constant. To continuously monitor the deuterium signal, the 
spectrometer has a dedicated deuterium channel. When you “lock your sample”, you tell 
the lock system to monitor the solvent's signal. Deuterated solvent in proton NMR is also 
critical to avoid excessive protic solvent signals. This lowers the water signal that 
compromises signal sensitivity. 
 
160 aa long D-Raf (isoform B) N-terminal segment 
Before studying the 117 aa long construct, as described in this work, we have studied the 
160 aa long D-Raf (isoform B) N-terminal segment (Figure 3.4) fused to GST tag 
(plasmid pGEX). MW of D-Raf 160 aa alone is 18.6 kDa, the MW of GST-D-Raf 160 
fusion protein is 47 kDa. The plasmid was sent for DNA sequencing (see Appendix for 
the construct DNA sequence): 
                        10                          20                            30                        40                  
GSSESSTEGD    SDLYDPLAEE     LHNVQLVKHV   TRENIDALNA 
                     50                        60                            70                         80 
KFANLQEPPA   MYLIGESSKA     ELNTTWVLGN     PTPTSKLFIK  
                      90                       100                      110                          120                                                     
YPTYVYVCIS   RLWFLPTEYQ   ELTSKLHELE     AKEQELMERL 
                    130                       140                       150                        160                                                      
NSQDQQEDSS   LVERFKEQPH    YQNQTQILQQ    QRQLARIHRD 
Figure 3.4: Sequence of D-Raf (isoform B) 160 aa N-terminal segment WT. 
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In figure 3.4, the sequence segments with colored background (either yellow or cyan) 
are the added portion that differentiates D-Raf isoform A (the short construct) from D-
Raf isoform B (the long construct). The sequence segments without background color 
match exactly the 117 aa long D-Raf (isoform A) N-terminal segment (studied in this 
work), it is shorter by 43 aa. The sequence segments with cyan background are 
repetitions that appear also in the isoform A (short) construct (underlined sequence 
segment). Notice that the putative phosphorylation 'TSK' appears twice in the long 
construct (isoform B). The 42 aa long insert segment is hydropathically neutral 
(GRAVY=0; grand average of hydropathy) whereas the 117 aa construct (short) is 
moderately hydrophilic (GRAVY= -1.069; max hydrophilic value is for arginine, -4.5, 
and maximum hydrophobic value is for isoleucine +4.5) [22,23]. The 19 aa stretch from 
L77 to L95 is especially hydrophobic (GRAVY= +1.084), these aa are shown in the 
sequence above in bold letters and graphically in Figure 3.5:     
 
 
 
 
 
 
 
 
 
 
Figure 3.5:  Window size of 9 aa, Kyte-Doolittle hydropathy plot [22,23] for the 160 aa 
long D-Raf WT (isoform B) N-terminal construct. Though most of the protein is 
hydrophilic, its line (blue) stays below zero for most of the sequence, there is 19 aa 
stretch of hydrophobic aa between the 77th d the 95th aa where the blue line is above zero. 
This 19 aa stretch, which is not present in D-Raf isoform A N-terminal, is predicted to be 
either in a hydrophobic core or to take part in protein-protein interaction as a hydrophobic 
patch. The red line is at hydrophobicity score of 1.6 and designates an empirical cutoff 
value for transmembrane segments where window size of 19 aa is relevant.  
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We over-expressed the 160 aa WT D-Raf (isoform B) N-terminal segment in minimal 
media (see Appendix for formula). The fusion protein was cleaved with Thrombin 
(0.01U/ml, RT, 4 hrs), test cleavage results are shown in Figure 3.6:    
 
 
 
 
 
 
 
 
 
Figure 3.6: Thrombin “test-cleavage” results of 160 aa WT D-Raf (isoform B) N-
terminal segment are shown on 12% SDS-PAGE gel. The rightmost lane shows low 
molecular weight marker bands, the MW of each of these bands is indicated to the right 
in kDa. The time for cleavage is in Hours. '0', fusion protein solution with Thrombin at 
the moment of adding the Thrombin. We have conducted two cleavage experiments: one 
with 0.02 U/μl and the other 0.01 U/μl (units of Thrombin per μl of protein fusion 
solution), both conducted over 8 hours. Samples were take after: 0.5, 1, 2, 4.5, and 8 
hours. The thick bands that migrate near the 31 kDa marker are GST. The increasing 
bands that migrate close to the 21.5 kDa marker line are the 160 aa WT D-Raf (isoform 
B) N-terminal segment. The bands of decreasing intensity that migrate above the 45 kDa 
marker line are the fusion protein (GST-D-Raf), the fusion construct was cleaved by 
Thrombin. 
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The next step was to try to purify the cleaved fusion-protein solution using a size-
exclusion column. We found that the 160 aa D-Raf migrated abnormally (Figure 3.7) 
and appeared heavier than its expected 18.6 kDa (it eluted before the heavier GST-linker 
segment which weighs ~28.4 kDa).  
 
              Lane number: 01 to 10                                    Lane number: 11 to 21          
        0    0   0   0   0   0    0    0   0    1                 1    1    1   1   1   1    1   1   1   2   2     
 M   1    2   3   4   5   6    7    8   9    0  M    M    1    2   3   4   5    6   7   8    9   0   1    M     
 
Figure 3.7: The 160 aa long D-Raf (isoform B) N-terminal segment construct eluates 
before other higher-weight proteins do from the size-exclusion column [26 mm 
diameter, 100 cm long, containing Sephacryl S-100 High-resolution beads]. 12% SDS-
PAGE gel shows: M, low weight marker bands (from top to bottom [kDa]: 97.4, 66.2, 
45.0, 31.0, 21.5, 14.4); lane '01', protein solution (cleaved fusion protein with Thrombin) 
loaded on the size-exclusion column; lane '02', fusion protein solution before cleavage 
with Thrombin, lower band is GST, middle wide band is the fusion protein, upper thin 
band is contamination that eluted with the fusion protein in the glutathione column; 
lanes '03' to '11' show protein samples from the 'Forward' rack of the fraction collector 
(tubes F1, F40, F70, F120, F125, F130, F135, F140), the 160 aa WT D-Raf (isoform B) 
N-terminal segment construct eluates into tubes between F120 to F140, as shown in 
lanes from '06' to '10'. D-Raf co-eluates with higher molecular weight proteins, weighing 
between 66.2 and 97.4 kDa. 'Back' rack protein samples are shown at lanes '11' to '21' 
(respectively: B1, B5, B10, B15, B20, B25, B30, B35, B40, B105, B135). The 26 kDa 
GST eluates in lanes '14' to '19' (B15 to B40). Notice, the higher weight GST (26 kDa) 
eluates before the lower weight D-Raf construct (18.6 kDa). 
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We tried to purify the protein eluted from the size-exclusion column using centrifugal 
ultrafiltration (Figure 3.8). However, we had no success as the protein aggregated and 
precipitated.  
                                M                   S2     S1   FT          S2      S1     FT        M 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Amicon Ultra-15 centrifugal unit with Ultracel-50 membrane (cat # UFC 
905008) of 50 kDa cutoff did not separate the oligomeric 160 aa D-Raf (isoform B) N-
terminal segments construct complex into monomers. This experiment indicates that the 
160 aa D-Raf construct forms high order multimers or an amyloid-like precipitate in 
SEC buffer (pH 6.0). The 12% SDS-PAGE gel shows: 'M', low weight marker bands 
(from top to bottom [kDa]: 97.4, 66.2, 45.0, 31.0, 21.5, 14.4); 'FT', Flow-through the 50 
kDa cutoff membrane, these lanes are virtually devoid of protein. If the complex was 
loose some of the D-Raf construct (18.6 kDa) should have pass through the membrane; 
'S1', The protein that did not pass through the 50 kDa cutoff membrane diluted 1:10;  
'S2', same as S1 but diluted 1:100; The 'S' fractions contain the D-Raf construct, lower 
bands beneath the 21.5 kDa marker bands.  
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CHAPTER 4. EXPERIMENTAL ANALYSIS 
 
Mass Spectrometry 
Mass spectrometry is an analytical tool used for measuring the molecular mass of a 
sample. For large samples such as biomolecules, molecular masses can be measured  to 
within an accuracy (theoretically) of 0.01% of the total molecular mass of the sample, 
i.e. within a 1 Dalton (Da) error for a sample of 10 kDa. This is sufficient to allow minor 
mass changes to be detected, e.g. the substitution of one amino acid for another. We 
used for the D-Raf study the matrix assisted laser desorption/ionization (MALDI) mass-
spectrometric technique on a time-of-flight (TOF) mass-spectrometer. This spectrometer 
operates on the principle that when a temporally and spatially well defined group of ions 
of differing mass/charge (m/z) ratios are subjected to the same applied electric field and 
allowed to drift in a region of constant electric field, they will traverse this region in a 
time which depends upon their m/z ratio. Our first experiment (Figure 4.1) indicated that 
the protein sample contains fragmented proteins, these originated from over-cleavage by 
the protease (Thrombin). From the mass of the fragments we learned that there is non-
canonical cleavage site 25 aa from the construct C-terminal, where the sequence reads: 
LVERF/KEQPH. This sequence has some resemblance to Thrombin canonical site: 
LVPR/GS. Another cleavage site is 4 aa from the C-terminal, where the sequence reads: 
QLAR/IHRD.  These cleavage sites were not predicted by the PeptideCutter tool 
(Chapter 3). We got clean mass-spectra after optimizing the cleavage conditions (Figure 
4.2; for the exact cleavage conditions see Chapter 3). The measured masses of the full-
length N-terminal segment protein (13.638 kDa and 13.672 kDa) agree with the value 
predicted by ProtParam tool (13.704 kDa; Chapter 2).  
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Figure 4.1: Mass-spectrometry (MALDI-TOF) of an impure sample of D-Raf (isoform 
A) N-terminal segment 117 aa. This sample contained fragments of the N-terminal 
segment. The right-most peak (13672.24 m/z) corresponds to the full length (117 aa) N-
terminal segment. The peak at 10542.29 m/z (corresponds to 91 aa segment from the N-
terminal toward the C-terminal) and the peak at 3580.122 m/z (corresponds to the 
remaining 25 aa up to the C-terminal) add up in mass to the full length peak (117 aa 
long). These fragments were created by cleavage at LVERF/KEQPH. The peaks at 
5279.8 m/z and 6843.6 m/z correspond, respectively, to the peak at 10542.29 m/z and 
13672.24 m/z; the difference between the two respective couples is the doubled charge 
(i.e., in the ratio m/z the z equals now +2 instead of +1). One can detect another 
fragment of 112 aa long (12993.31 m/z) and its corresponding peak near 6496.65 m/z, 
the cleavage site is in: QLAR/IHRD, which has some similarity to Thrombin canonical 
cleavage site LVPR/GS. The buffer solution was 10 mM Sodium Phosphate and the 
protein concentration was 0.05 mg/ml. 
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Figure 4.2: Mass-spectrometry (MALDI-TOF) of a pure sample of D-Raf (isoform A) 
N-terminal segment (117 aa). This sample contains one fragment of the N-terminal 
segment. The right-most peak (13637.93 m/z) corresponds to the full length (117 aa) N-
terminal segment. The peak at 6828.99 m/z has nearly the same mass as the peak at 
13637.93 m/z, but with doubled charge (i.e., in the ratio 'm/z' the 'z' equals now +2 
instead of +1, but 'm' stays the same). No other significant peaks are detected. The buffer 
solution is 10 mM Sodium Phosphate and the protein concentration was 0.05 mg/ml. 
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Protein N-terminal sequencing by Edman degradation 
ying the purity of a protein 
 the 
dman degradation (Figure 4.3), developed by Pehr Edman, is a method for sequencing 
ns, 
d 
 
igure 4.3
Protein sequencing is another experimental tool for stud
sample. The method determines the identity of the first 5 aa of a protein sequence. If
sample is impure, i.e., contains several oligopeptides with different N-terminal sequence, 
then we would detect several candidates as N-terminal amino acids. 
 
E
aa in a peptide. In this method, the amino-terminal residue is labeled and cleaved from 
the peptide without disrupting other peptide bonds between other aa. Phenyl-iso-thio-
cyanate is reacted with the uncharged terminal amino group, under mildly alkaline 
conditions, to form a phenyl-thio-carbamoyl derivative. Then, under acidic conditio
this derivative of the terminal amino acid is cleaved as a thiazol-inone derivative. The 
thiazol-inone amino acid is then selectively extracted into an organic solvent and treate
with acid to form the more stable phenyl-thio-hydantoin (PTH)- amino acid derivative 
that can be identified  using chromatography. This procedure can then be repeated again
to identify the next amino acid. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F : Schematic description of the chemistry involved in in the “Edman 
degradation” process [21].  
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We sent two protein samples (each contained 0.7 mg/ml protein in 10 mM Sodium 
 at 
 
h both the 
 “Prosorb” 
 
er” 
 N-terminal five subsequent 
Phosphate) for sequencing in the “protein facility” located in the BBMB department
ISU: one sample was of protein produced before optimizing the cleavage conditions 
('PRE') and the other contained protein produced after the optimization ('POST'). The
samples were diluted with 0.1% w/v tri-fluoro-acetic acid (TFA) in water (TFA is a 
modifier). Modifiers are substances added to the mobile phase in HPLC 
chromatography, usually in relatively low concentration, that interact wit
stationary phase and sample constituents to alter retention. Interaction with sample 
components varies, so selectivity can be adjusted by changing the modifier 
concentration. Each protein sample was loaded onto an Applied Biosystems
(trademark) device. The protocol for sample preparation using this device was followed
and the “Prosorb” membrane was loaded onto a pre-conditioned filter for sequence 
analysis. The instrument used was the “494 Procise Protein Sequencer/140C Analyz
from Applied Biosystems. The sequencing results are shown in Table 4.1: 
 
amino acid(s) 
Sample: 
Cycle 
N  
'PR
protein 
T' 
umber
E' 'POS
sample 
protein 
sample 
1 G K G 
2 S E S 
3 S Q S 
4 E P E 
5 S H S 
Table 4.1: Five aa N-terminal sequen g resul or th rotein sa les prepared before 
to the 
cin ts f e p mp
cleavage conditions optimization ('PRE') and after optimization ('POST'). Two N-
terminal sequences are detected for the 'PRE' sample: 'GSSES' which corresponds 
N-terminal of the 117 long D-Raf (isoform A) WT, and 'KEQPH' which corresponds to 
a 25 aa long segment starting at the C-terminal end of this construct (117 long D-Raf). 
Only one N-terminal sequence is detected for the 'POST' sample, therefore it can be 
concluded that the 'POST' sample is pure.  
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Edman degradation sequencing of the 'PRE' protein sample detected two N-terminal 
ed 
 
3 
he 'POST' protein sample was pure, i.e., it contains one type of protein segment – the 
 
ircular Dichroism
sequences:GSSES and KEQPH, peaks for the corresponding fragments can be observ
in the mass-spectrometry results (Figure 4.1) as peaks 13672.24 m/z and 3580.122 m/z, 
respectively. The 4 aa long peptide that arises from cleavage of the 117 aa segment to 
113 aa N-terminal plus 4 aa C-terminal, at the cleavage site QLAR/IHRD, was not 
detected by the sequencing protocol because it was not present in the sample (it was
filtered out during the buffer exchange; the filter cutoff is 3 kDa). The peak for the 11
aa fragment is observed in the mass-spec results (Figure 4.1) at 12993.31 m/z. 
 
T
117 aa D-Raf (isoform A) N-terminal segment. We conclude this from the fact that its 5
aa long N-terminal sequence result was unique: GSSES. In addition, only one peak was 
detected in the mass-spectrum (Figure 4.2). 
 
 
C  
omenon in which light absorption differs for different directions of 
0 
 the 
e of the protein buffer should be as low as possible, that is why we 
 
r 
2) uld be relatively small (usually ~0.5 
tion 
Dichroism is the phen
polarization. In circular dichroism (CD) experiment the detector measures the difference 
in absorption of left- and right-circularly polarized light, for ultraviolet light with 
wavelengths between 190 and 260 nm. Measurements were done on the Jasco J-71
spectropolarimeter. Limited source intensity (Xe lamp) and limited dynamic range of
detector dictate: 
1) The absorbanc
“buffer exchanged” from SEC buffer to 10 mM Sodium Phosphate buffer before 
measuring the CD spectra. Both the lower ionic strength of the new buffer and the
lower specific absorbance of phosphate (relative to chlorine) contribute to the lowe
“blank” absorbance of the buffer alone, i.e., without the protein solute. For the same 
reason we did not add to the Sodium Phosphate solution di-thio-threitol (DTT), 
imidazole or any other organic compound. 
Protein concentration in the CD sample sho
mg/ml is recommended). In our case, the detector was saturated at this concentra
and we needed to dilute the sample by 1:10 ratio to get a good signal. 
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3) 
More details regarding the CD experiment
The sample cell should be made from quartz (low absorbance of UV). 
4) Purging the spectropolarimeter space from oxygen by streaming in ample nitrogen 
gas (10 psi). Purging allows for higher intensity of light reaching the sample and 
eliminates the production of ozone that attacks the optics inside the 
spectropolarimeter.  
 
 
 shown in Table 4.2: Measurement conditions and parameters are
Temperature RT 
Cell diameter 1 cm 
Range 260-190 nm 
cell volume ~400 ml 
Recommended sample 550 ml of 0.05 otein solution 
(vol, concentration) 
 mg/ml pr
Sensitivity 20mdeg 
Resolution 0.2 nm 
Speed 5  0 nm/min
buffer salt Sodium Phosphate dibasic anhydrose 
(MW 141.96) 
Table 4.2: Measurem roism 
asco 
he result of the CD experiment for D-Raf N-terminal segment 117 aa is shown in 
re 
af 
08 
he 
ent conditions and parameters used in the circular dich
spectral measurement of 117 aa D-Raf (isoform A) WT N-terminal segment on a J
J-710 spectropolarimeter. 
 
T
Figure 4.4. Characteristic CD spectra for common secondary structures in proteins a
shown in Figure 4.5. Qualitative comparison between the two figures, 4.4 and 4.5, 
clearly shows the double-dented signature of alpha-helices in D-Raf spectrum. D-R
dents appear at 209.4 nm and 221.4 nm (Figure 4.4). The spectral 'dents' are at about 2
nm and 222 nm in Figure 4.5. The CD line in Fig. 4.4 crosses the 'x-axis' twice: at 200.5 
nm and 249.4 nm. By the lack of a 'positive' (i.e., above axis) peak around 215 nm in 
Figure 4.4 we conclude that the amount of random coil secondary structures in our 
construct is relatively small, and random coils may be only minor characteristic of t
secondary structure. Also in Figure 4.4, there is a subtle 'shoulder' at about 192.6 nm. 
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This shoulder may indicate the existence of extended beta strands. In Figure 4.5 the 
positive peak of of beta-chains is around 193 nm. Notice that alpha-helix crosses the 
axis' at ~206 nm (Figure 4.5), where as the spectral line crosses at 200.5 nm in Figure 
4.4); this fact may indicate the contribution of random coil structure that has minima at
~197 nm. We did not analyze the spectra quantitatively because the inherent inaccuracy 
in such analysis is about +/-10% which is relatively poor.  
 
'x-
 
onclusion from the CD experimentC  
t 117 aa is folded in-vitro and has a relatively high D-Raf (isoform A) N-terminal segmen
content of helical secondary structure. This result bolsters the predictions of GOR and 
SMART proteomics tools as describes in Chapter 3.  
 
 
Figure 4.4: CD spectrum of D-Raf (isoform A) N-terminal segment (117aa) WT. 550 μl 
of 0.05 mg/ml protein solution. 10 mM Sodium Phosphate buffer. The 'two-dented' 
signature (local minima at ~209.4 nm and at ~221.4 nm) of helical secondary structu
easily detected. 
re is 
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Figure 4.5: CD (crosshatched) spectra of homo-polypeptides in the random coil, alpha-
m 
helical, and beta-chain conformations. The shaded areas indicate the range of values. 
The dotted zone is of ORD spectra and not relevant to this discussion. Figure taken fro
[18] and references therein.
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Nuclear Magnetic Resonance Spectroscopy 
Protein preparation of 117 aa D-Raf (isoform A) for NMR characterization was 
concentrated down to 675 μM in SEC buffer (see Appendix for details about the SEC 
buffer) supplemented with 10% D2O. All NMR experiments were performed on a 700 
MHz Bruker Avance II system, at 30 °C (temperature controlled by BVT 3000 digital 
VT controller). Signal collected by Bruker Z-gradient inverse TXI 1H/13C/15N five mm 
cryoprobe.   
 
Standard Bruker BioSpin pulse sequences were employed. Data processed and 
interpreted using nmrPipe [24] and nmrViewJ software [25].  
 
Nuclear Magnetic Resonance Spectroscopy (NMR) is the name given to the technique 
which exploits the magnetic properties of nuclei and measures their radio frequency 
absorptions. In its simplest form NMR allows identification of individual atoms in a 
pure molecule. In ”protein NMR” we probe 'spin-half' nuclei. When placed in a 
magnetic field, NMR active nuclei (like 1H or 15N) resonate at a specific frequency, 
dependent on strength of the magnetic field. However, depending on the local chemical 
environment, different protons in a molecule each resonate at slightly different 
frequencies. By understanding different chemical environments, the chemical shift can 
be used to obtain some structural information about the molecule in question to assign 
signals to an atom or a group of atoms. 
 
Some of the most useful information for structure determination comes from scalar 
coupling (a special case of spin-spin coupling) between NMR active nuclei. This 
coupling arises from the interaction of different spin states through the chemical bonds 
of a molecule and results in the splitting of NMR signals into recognizable patterns 
based on the pairing of spin states. As a result, this coupling can give us information 
about the connectivity of atoms in a molecule. Through space proximity is studied using 
the NOE effect (nuclear Overhauser effect: the transfer of spin polarization from one 
spin population to another via cross-relaxation). 
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2D 1H,15N-HSQC  
The HSQC (heteronuclear single quantum correlation) experiment is determined by the 
radio-frequency pulse sequence described in Figure 4.6: 
 
Figure 4.6: 2D 15N-HSQC experiment generic pulse sequence [29]. Narrow rectangles 
designate 90° pulses. Wide rectangles designate 180° pulses. All rotations are around the 
x-axis unless designated otherwise. 'τ', fixed delay. 't1', evolution period. 't2', acquisition 
period. 'FID', free-induction decay. 'GARP', complex pulse used for spin decoupling 
(globally optimized alternating phase rectangular pulse). 
 
In the 2D HSQC (heteronuclear single quantum correlation) experiment the resulting 
spectrum is two-dimensional with one axis for 1H and other for a heteronucleus, most 
often 15N. A heteronucleus in NMR terminology is a nucleus other than proton. The 
spectrum contains a peak for each unique proton directly attached to the heteronucleus 
being considered. Thus, if the chemical shift of the proton is known, the chemical shift of 
heteronucleus can be determined, and vice versa.  It is widely used because it is based on 
proton-detection, offering high sensitivity when compared with a conventional nitrogen-
detected experiment. 
 
Each residue of the protein (except Proline) has an amide proton attached to a nitrogen in 
the peptide bond. If the protein is folded, the peaks are usually well dispersed, and most 
of the individual peaks can be distinguished. Being a relatively cheap and quick 
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experiment, the HSQC is useful to screen candidates for structure determination by 
NMR. The number of peaks in the spectrum should match the number of residues in the 
protein (though sidechains with nitrogen-bound protons will add additional peaks: Arg, 
His, Gln, Asn). The labor-intensive process of structure determination is usually not 
undertaken until a good HSQC is obtained. The HSQC experiment is also useful for 
detecting interactions with ligands, such as other proteins or drugs. By comparing the 
HSQC of the free protein with the one bound to the ligand, it is possible to find the 
changes in the chemical shifts of the peaks, which is most likely to occur in the binding 
interface. 
It is not possible to assign the HSQC spectrum by itself, or in other words, to determine 
which of the peaks correspond to a particular residue in the protein. For that purpose, 3D 
heteronuclear experiments are needed to be done.  
 
HSQC data collection 
Relevant parameters for HSQC data collection are summarized in Table 4.3: 
 
Dimension Direct: HN Indirect:   15N 
Total number of data points (Re+Img) in acquisition 
mode  
2048 256 
Phase-cycling acquisition mode DQD Echo-AntiEcho 
Sweep-width (spectral width) [Hz] 6648.936  1419.037 
Carrier wavelength [MHz] 700.130 70.944  
center position (i.e., spectrum reference) [ppm] 4.725 119.042 
 
Table 4.3: Specific parameters used for collecting data in HSQC experiment of D-Raf 
(isoform A), both WT and Mutant T60E, 117 aa N-terminal segment. 
 
HSQC signal processing steps 
1) “Sine Bell”: The data in the direct dimension (HN) was first multiplied by an 
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adjustable “Sine Bell”, that is, a sine-window with an 'offset', 'endpoint' and 'power'. 
The 'offset' specifies the starting point of the sine-bell in units of pi radians. We used 
0.49 so it is more of a cosine-window, which starts at height a little smaller than 1. 
The 'ending point' of the sine-bell, also in units of pi radians, was chosen to be 0.99; 
the window goes close to zero height at the last point. The 'power' specifies the 
exponent of the sine-bell; we chose 1.0 to get ordinary sine-bell shape. The first data 
point in the data vector was multiplied by 0.5. 
2) “Zero Filling”: we extended the data size by appending zeros. This is used primarily 
on time-domain data to increase the digital resolution of the corresponding spectrum. 
We have rounded the final zero-fill size up to the nearest power of two. This speeds up  
Fourier transform step which follows. 
3) “Fourier transform”: the transform gives us information about the chemical shifts of 
nuclei in our protein sample. Only the intensity factors are preserved, the phase data is 
discarded. 
4) “Phase Correction”: sampling delays (such as instrumental delays) necessitate both 
zero-order (frequency independent) and first-order (linearly dependent on the 
frequency) phase corrections of the Fourier transformed data. A value of -90° for the 
zero-order correction and +90° for the first-order correction gave the best result, i.e., 
the spectral peaks were positively absorptive and not dispersive. Any imaginary values 
resulting from this procedure were deleted. 
5) “Transposition”: 2D Transpose XY->YX exchanges the rows  (x-axis)  and  columns 
(y-axis) for further data processing of the second dimension (15N; the 'indirect 
dimension'). 
6) The 15N dimension was processed in the same manner as the HN dimension (Sine-
belled, zero-filled and Fourier transformed). However, in the phase correction step 
different values were needed: +90° zero-order correction, and no (i.e., zero) first-order 
correction. Subsequently, the data matrix was transposed again. 
7) Finally, “baseline correction” to both dimensions (HN & 15N) was performed. 
● The nmrPipe processing program script used for the HSQC data is show in the 
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Appendix. 
HSQC experiment spectrum  
2D 1H,15N-HSQC NMR spectra of 117 aa D-Raf (isoform A) WT (black peaks) and 
Mutant T60E (red peaks) are shown in Figure 4.7. Originally, the WT signal was ~2.5 
stronger relative to Mutant signal because its protein concentration was proportionally 
higher (675 μM vs. 270 μM, respectively). The spectra intensities were adjusted so the 
peaks of WT and Mutant would be of similar area in Figure 4.7. 
 
The spectral features gleaned from Figure 4.7 are summarized in the list below: 
1) Protein sample of 675 μM gives strong enough signal to show peaks from virtually all 
the aa in the protein construct: there are more than 120 distinct and strong black peaks 
(D-Raf WT), therefore we can conclude that we get strong enough signal from the 
protein sample about most of the aa (117 aa). Over-all we counted 157 strong peaks, 
42 (=2*[6+15]) of them are expected to be repetition of Asn and Gln. About 5 more 
may arise from His, Arg and Lys side chains. We notice ~9 peaks that have relatively 
small area but are high in intensity, these may arise from short segment of the protein 
that assumes two conformations. Alternative explanation will attribute these few 
peaks to a second species in the protein solution such as oligopeptide contamination. 
Note, the 4 prolines would not have corresponding HSQC peaks.  
 
2) The protein is folded: this conclusion is indicated by the wide peaks dispersion in the 
spectrum, 2.5 ppm in the HN axis and 19 ppm in the 15N axis. If the protein were not 
been folded the chemical shifts would equal those characterizing random coil 
conformation. According to Table 4.4 the backbone HN chemical shift max spread is 
0.57 ppm (Trp was not included as there is no Trp in the 117 aa D-Raf isoform A N-
terminal construct). The chemical shift spread for HN from sidechains is ~1.0 ppm 
(Table 4.4). The chemical shift spread for 15N is less sensitive to secondary and 
tertiary structure, the estimated random-coil spread is ~15 ppm [27].   
 
3) Chemical shift dispersion shows that only a small number of aa are affected by the 
mutation T60E in the 117 aa D-Raf isoform A N-terminal construct: most of the red 
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peaks (Mutant) cover the black peaks (WT) exactly, only ~12 aa (~10% of the 117 
aa) are significantly shifted. The shifted red peaks are hypothesized to be in the 
spatial vicinity of the mutated amino acid, either along the backbone or close in space 
but further along the backbone (e.g., due to protein folding). 
4) The doubled peaks on the upper left corner (15N: 111-113 ppm, 1H: 6.65-7.65 ppm) 
of Figure 4.7 are from Asn and Gln sidechains. Chemical shifts for Asn and Gln 
sidechains in proteins, collected by the BioMagResBank [28], is shown in Figure 
4.8(b). The two protons in the distal amino terminal of these sidechains experience 
different electronic shielding because one of them is closer to the carbonyl oxygen 
and because the peptide bond is rigid since it has a character between a single and a 
double bond.  
5) The doubled peaks on the lower left corner (15N: 120-121 and 124-125 ppm, 1H: 
7.12-7.42 ppm) of Figure 4.7 arise probably either from the 5 Lys, or the 6 Arg, or the 
5 His sidechains. We suggest this because: (i) the number of the peaks is 5 and we 
have only 5 to 6 basic residues in the sequence, and 5 His; (ii) Arg NE chemical shift 
is ~ 88 ppm, Lys NZ shift is ~50 ppm, His ND1 shift 190.48 ppm, His NE2 shift 
176.76 ppm [28]. Arginine HE chemical shift is ~ 7.17 ppm and lysine HZ chemical 
shift is ~7.50 ppm [28]. No chemical shift value is recorded for His HD1. The five 
black peaks are very close to 7.32 ppm,  they center around 7.2 ppm, which is very 
close to Arg 7.17 ppm. The lysine and arginine sidechain cross-peaks were probably 
folded ('aliased') because the sweep width was too small to contain them (runs from 
100 ppm to 136 ppm); (iii) The five black peaks (WT) are within less of 1 ppm from 
each other. This fact indicates that theses nitrogens experience similar chemical 
environment, such may be the case with Arg NE; (iv) the acidic pH 6.0 is low enough 
to stabilize the protons on Lys sidechain (pKa 10.53) and Arg sidechain (pKa 12.53) 
to give a signal, His (pKa 6.0); (v) the T60E mutation is expected, by introducing a 
negative electrical charge,  to change the chemical shift  and affect especially 
positively charge aa as Arg and Lys. Notice that the 5 red peaks of the mutant 
construct (15N: 120-121 ppm, 1H: 7.12-7.42  ppm) follow nearly the same pattern as 
the five black peaks of the WT, but are significantly shifted. To conclude, the 5 peaks 
that repeat twice probably arise from Arg sidechains. Further analysis of the 3D NMR 
spectra is needed. 
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Figure 4.7: 2D 15N-HSQC NMR spectra of 117 aa D-Raf (isoform A) WT (black peaks) 
and Mutant (T60E, red peaks). The spectra intensities were adjusted so the peaks of WT 
and Mutant would be similar.    
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Table 4.4: Random coil 1H chemical shifts for the 20 common aa [26]. The chemical 
shifts of backbone amide protons (HN) show limited dependence on amino acid type and 
have mean of 8.3 ppm and a standard deviation of 0.7 ppm.
46 
Figure 4.8: (a) Aliphatic 1H chemical shifts. The mean and standard deviations for each 
1H nucleus type were obtained from the database of chemical shifts at BioMagResBank 
[28]. The bars extend one standard deviation in either direction from the mean value. 
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Figure 4.8 continued: (b) Non-aliphatic sidechain 1H chemical shifts. The mean and 
standard deviations for each 1H nucleus type were obtained from the database of 
chemical shifts at BioMagResBank [28]. The bars extend one standard deviation in 
either direction from the mean value.  
 
6) The WT HSQC spectrum shows (black peaks in Fig. 4.7) about nine minor peaks that 
appear to be absent from the Mutant spectrum (red peaks in Fig. 4.7). The characteristics 
of these subgroup are unique: peaks areas are small, high in intensity, and their shape is 
nearly perfectly round. These peaks may arise from small-molecule contamination 
(impurities), but most likely they are due to short segment flexibility (a loop) that allows 
that segment to obtain two or more metastable conformations or proline isomerization 
states and side chain conformations of aromatic groups. There is one peak of this 
subgroup that appears to be isolated (15N: ~126.5 ppm, HN: ~7.75 ppm), however, 
chemical shift is also very sensitive to conformation. The average intensity of this 
subgroup peaks is only 20% of the average intensity of all the peaks (the major peaks). 
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3D 1H,15N-TOCSY-HSQC and 3D 1H,15N-NOESY-HSQC 
2D spectra like NOESY (nuclear Overhauser effect spectroscopy), or TOCSY (total 
correlation spectroscopy) of large proteins are often crowded with signals. Therefore, we 
spread out these spectra in a third dimension (15N), so that the signals are distributed in 
a cube instead of a plane. This spreadout is achieved by combining HSQC and NOESY 
or TOCSY in a single 3D experiment.  
 
The TOCSY pulse sequence (Figure 4.9) transfers magnetization through the chemical 
bonds between adjacent protons. Thus in a conventional correlation spectroscopy, an 
alpha proton transfers magnetization to the beta protons, the beta protons transfers to the 
alpha and gamma protons if any are present, then the gamma proton transfers to the beta 
and the delta protons, and the process continues. In total correlation spectroscopy, the 
alpha and all the other protons are able to transfer magnetization, during the 'mixing' 
period (60 ms in our experiment), to the beta, gamma, delta, epsilon if they are 
connected by a continuous chain of protons. The continuous chain of protons are the 
sidechain of the individual aa. Thus this experiment is used to build so called spin 
systems, that is, build a list of resonances of the chemical shift of the peptide proton, the 
alpha protons and all the protons from each residue’s sidechain. Which chemical shifts 
corresponds to which nuclei in the spin system is determined by the conventional 
correlation spectroscopy connectivities and the fact that different types of protons have 
characteristic chemical shifts. 
 To connect the different spin systems in a sequential order, the NOESY is used (Figure 
4.10 and Figure 4.11). Because this experiment transfers magnetization through space, 
during the 'mixing' period (100 ms in our experiment), it will show crosspeaks to all 
protons that are close in space (theoretically within 5 Angstroms) regardless of whether 
they are in the same spin system or not (Figure 4.11). Neighboring residues are 
inherently close in space, so assignments can be made by the NOESY peaks with other 
spin systems (usually, the preceding amino acid). Practically, NOEs may be very weak, 
and only few connectivities would be detected. To establish a sequence of spin systems 
more than a couple of amino acids should show significant NOE crosspeaks. As more 
and more unique amino acid dipeptide fragments or tripeptide fragments are identified, 
more of the sequential assignment can be completed. 
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Figure 4.9: 3D 1H-15N TOCSY-HSQC experiment generic pulse sequence [29]. Narrow 
rectangles designate 90° pulses. Wide rectangles designate 180° pulses. All rotations are 
around the x-axis unless designated otherwise. 'τ', fixed delay. 't1', evolution period (1st 
dimension). 't2', evolution period (2nd dimension). 't3', acquisition period (FID, free-
induction decay). 'decouple', any complex pulse used for spin decoupling (such as 
GARP). Φ1,2,3 phase cycling, where in this scheme: Φ1 = 180x,-180x;  Φ2 = 360x,-360x; 
Φ3 = 90x,-90x. 'SL', spin locking with direction in sub-script. 'DIPSI-2', broadband 
decoupling scheme (decoupling in the presence of scalar interactions) used during the 
'mixing period', but WALTZ, MLEV, and GARP could also be used. 
 
 
 
 
 
 
 
Figure 4.10: 3D 1H-15N NOESY-HSQC experiment generic pulse sequence [29]. 
Narrow rectangles designate 90° pulses. Wide rectangles designate 180° pulses. All 
rotations are around the x-axis unless designated otherwise. 'τ', fixed delay. 't1', evolution 
period (1st dimension). 't2', evolution period (2nd dimension). 't3', acquisition period (FID, 
free-induction decay). 'S', 15N dimension. 'I', 1H dimension. 'decouple', any complex 
pulse used for spin decoupling (such as GARP). Φ1,2,3 phase cycling, where in this 
scheme: Φ1 = 180x,-180x;  Φ2 = 90x,90x,-90x,-90x; Φ3 = 360x,-360x. 'τm', mixing time 
(NOE and scalar exchange transfer are achieved during this period). 
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Figure 4.11: Through-space connectivities between the preceding amino acid (amino 
acid number 'i'; Valine in this case) to the following amino acid (amino acid number 
'i+1') amide proton along the backbone; 'd', distance (the subscripts indicate the involved 
nuclei). The longer the distance the weaker the NOE signal; dashed lines, non-labile 
protons correlated by scalar correlations (TOCSY); arrows: sequential inter-residue 
NOEs [26]. 
 
3D 1H-15N TOCSY-HSQC and 3D 1H-15N NOESY-HSQC data collection parameters 
Relevant parameters are summarized in Table 4.5: 
Dimension HN 1H 15N 
Total number of data points (Re+Img) 
 in acquisition mode  
4096 128 64 
Phase-cycling acquisition mode DQD States-
TPPI 
States-
TPPI 
Sweep-width (spectral width) [Hz] 6648.936 8401.600  1419.037 
Carrier wavelength [MHz] 700.133 700.133 70.952 
center position (i.e., spectrum reference) [ppm] 4.725 4.725 119.042 
Table 4.5: Specific parameters used for collecting data in TOCSY and NOESY 
experiments on 177 aa WT and Mutant (T60E) D-Raf (isoform A) N-terminal segment. 
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1H-15N TOCSY-HSQC and 3D 1H-15N NOESY-HSQC signal processing 
1) “Solvent  Filter”: we applied a time-domain convolution function for 'water' (solvent 
signal) subtraction. This convolution function is a low-pass filter of a sine-squared 
shape. 
2) “Sine Bell”: the same step as for the HSQC data, but this time the 'offset' was set to 
0.5 (cosine-window), 'ending point' set to 0.99, squared sine-bell (power 2). The first 
data point in the data vector was multiplied by 0.5. 
3) Subsequently, the date was zero-filled and Fourier transformed. For the first 
dimension (HN) zero-order phase correction of -20° was needed but no need arose for 
first-order phase correction. 
4) “Data Extraction”: data vectors were extracted in a sweep-width length. This step 
compensates for data-vector lengthening during the zero-filling prior to Fourier 
transform. 
5) Next, the second (1H) dimension was processed. Squared cosine-bell was applied. 
The first data point in the data vector was multiplied by 1 (i.e., no change). 
6) Again, he date was zero-filled and Fourier transformed. Zero-order phase correction 
of +90°, and +180° first-order phase correction were needed for the 2nd dimension 
(1H). 
7) The 3rd-dimension (15N) was processed exactly as the second dimension. 
8) Linear-prediction and “baseline correction” essentially the same as for processing the 
HSQC data were implemented. 
 
As a first step we tried to identify the aa comprising our protein construct (117 aa N-
terminal segment of D-Raf, isoform A, WT) from the TOCSY spectra. Due to 
degeneracy of TOCSY patterns only 8-12 species can be distinguished from among the 
20 canonical amino acids, prior to NOE-based sequence alignment. There is plasticity of 
TOCSY patterns. In proteins, local environment effects scalar-coupling and lead to 
variability in TOCSY patterns. We tabulated the HSQC peaks according to their pattern 
in the TOCSY spectra. The results of this analysis are shown in Table 4.6. Some amino 
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acids are clustered together because they have the same spin system, for example Ser, 
Asp, Asn, Phe, Tyr and His are all AMX spin system [26]. Gln, Glu and Met relate to 
the AM(PT)X spin system [26]. For some amino acids we found more seemingly 
matching patterns in TOCSY than the number of the amino acids in the sequence: Ala, 
Ile, Leu, Asp, Tyr, Glu, Gln. We found 32 HSQC peaks that showed in the TOCSY 
spectrum either only one HN peak or two peaks HN and HA. These could be explained 
both by the low signal emitted from certain amino acids (e.g., due to fast dynamics, i.e., 
in the intermediate exchange regime) or to isolated HN in side chains. We did not find 
any pattern resembling Arg or Lys, by comparing the TOCSY patterns to the patterns in 
Table 4.4 and Figure 4.8. 
 
Many of the TOCSY patterns resembled Gln and Glu patterns, several of them must be 
the Arg and Lys that have very similar pattern, but because of the following reasons it is 
hard to differentiate between the nearly resembling patterns:  (i) low signal to noise 
ratio, (ii) magnetization transfer from the amide proton to the aliphatic protons in the 
sidechains is not complete, therefore the signal from the peripheral aliphatic protons, 
such as the gamma carbon in Glu, is weak, and (iii) degeneracy in the secondary 
structure (high helix content), dictates similar chemical environment. 
 
Figure 4.12 is an example for the process involved in establishing that two amino acids 
are close in space (within 5 Angstroms). Shown are three two-dimensional (2D) strips. 
The right-most strip (with blue peaks) shows a peak pattern which highly resembles that 
of Isoleucine (Table 4.4 and Figure 4.8). The middle strip (with gray peaks) and left-
most strip (with red peaks) are of one and the same spin system. The blue peaks show a 
pattern which highly resembles that of Histidine (Table 4.4 and Figure 4.8). The 
proximity is suggested by a clear cross peak of the Ile alpha carbon proton with the 
amide proton of His (1H: 4.15 ppm) as shown in the middle strip.
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 aa Gly Ala Val Ile Leu Thr Ser,Asp,Asn, 
Phe,Tyr,His 
Gln/Glu/Met Arg Lys 
# 
in 
sequence 
 
2 7 4 4 15 4 33 
9/7/6 
2/4/5 
33 
15/16/2 
 
6 5 only 
HN 
or 
only 
HN&C
A 
~% 
In 
sequence 
1.7 6 3.4 3.4 12.8 3.4 28.2 28.2 5.1 4.3 
*  * * * * * * * *   
*   * * * * * * *   
*   *  * *  * *   
*   *  * *  * *   
*   *  * *  * *   
*   *  * *  * *   
*   *  * *  * *   
*   *   *  * *   
*   *   *  * *   
*      *  * *   
*      *  * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
*        * *   
        * *   
        * *   
        * *   
        * *   
 
Table 4.6: HSQC peaks sorted according to amino acid type (plausible) as judged by the 
respective pattern in the TOCSY spectra. 
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Figure 4.12: NMR 2D spectral strips taken from the 3D 1H,15N-TOCSY and 3D 
1H,15N-NOSEY spectra collected for the 117 aa D-RAF (isoform A) WT. The 'y-axes' 
in all three strips are along the 1H dimension; the 'x-axes' are along the HN dimension. 
Two spin systems are shown, probably they represent the couple Ile114-His115, there is 
only one Ile-His couple along the sequence. The TOCSY strip with the peaks colored 
blue has the coordinates [all in ppm] HN:  7.9-8.0, 1H: 0.5-9.0, 15N: 121.1523. The 
pattern of the blue peaks resembles that of Ile (Table 4.4 and Figure 4.8). The TOCSY 
strip with the peaks colored red has the coordinates [all in ppm] HN:  8.4-8.5, 1H: 0.5-
9.0, 15N: 123.2819. The pattern of the red peaks resembles that of His (Table 4.4 and 
Figure 4.8). The NOESY strip with the peaks colored gray has the same coordinates as 
the His TOCSY strip, and relates therefore to the same spin system shown by the red 
peaks. The His NOESY strip shows all the His TOCSY peaks but with an additional 
cross-peak that has the same 1H value as the Ile alpha carbon attached proton. This 
connectivity indicates that the two amino acids are close in space, and may even follow 
each other along the backbone. 
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CONCLUSION 
 
The overall goals of the research presented in this thesis were: (i) establish the protocols 
for expression and purification of the 117 amino acids long N-terminal segment of 
Drosophila Raf protein (isoform A), both WT and Mutant (T60E), and (ii) biophysically 
characterize these protein constructs. We can conclude that both WT and Mutant can be 
over-expressed (at 15 °C for 24 hours) by E. Coli (BL21 strain) in 15N-labeled minimal 
media, the expressed proteins are soluble and can be purified in SEC buffer of pH 6.0. 
The fact that the N-terminal segment contains two non-canonical sites of Thrombin 
cleavage dictates giving much care during the fusion-protein (GST-tagged) cleavage 
reaction. Not carrying the cleavage reaction to completion avoids the 'over cleavage', 
however, final protein yields are thus smaller. For future work, consideration should be 
given to replacing the Thrombin cleavage site with a different protease site, one that the 
N-terminal segment is not inherently sensitive to. We have also attempted expression 
and purification of the 160 aa D-Raf (isoform B) N-terminal segment that incorporates a 
short hydrophobic stretch, however the protein was highly unstable. It precipitated 
before the cleavage reaction and stayed in an oligomeric state after cleavage. 
Beginning with 4 liters of bacterial culture, our final yield of 117 aa WT D-Raf (isoform 
A) N-terminal segment was 0.5 ml NMR sample of ~675 μΜ protein concentration. This 
sample concentration was enough to give strong HSQC & TOCSY signals, however the 
NOESY signals were relatively weak in the 700 MHz NMR machine. Biophysical 
characterization indicated that the N-terminal segment is highly acidic (pI=4.72, 
carrying negative electrical charge of -12). The protein amino acid content is highly 
skewed toward Gln, Glu and Leu. Circular dichroism spectropolarimetry, NMR 
spectroscopy and predictive proteomics tools such as SMART and GOR indicated that 
the protein is folded and has relatively high helical content (both WT and Mutant). The 
fact that there are many amino acids of one type and the fact that most of the secondary 
structure is helical indicates a difficulty in making sequential assignments using the 
NMR spectra due to chemical shift degeneracy. It was possible to find several unique 
couples of amino acids (an example was given in Figure 4.12). This establishes a basis 
for future total assignment and determination of the protein structure.     
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APPENDIX 
 
Human B-Raf sequence (765 aa) 
MAALSGGGGG GAEPGQALFNG DMEPEAGAGRP AASAADPAI PEEVWNIKQM 
IKLTQEHIEA LLDKFGGEHN PPSIYLEAYEE YTSKLDALQQR EQQLLESLGN 
GTDF|SVSSS ASMDTVTSSS SSSLSVLPSS LS|VFQNPTD VARSNPKSPQ 
K|PIVRVFLPN KQRTVVPARC GVTVRDSLKK ALMMRGLIPE CCAVYRIQDG 
EKKPIGWDTD ISWLTGEELH VEVL|ENVPL TTHNFVRKTF FTLAFCDFCR 
KLLFQGFRCQ TCGYKFHQRC STEVPLMC|VN YDQLDLLFVSK FFEHHPIPQEE 
ASLAETALTS GSSPSAPASDS IGPQILTSPS PSKSIPIPQP FRPADEDHRN 
QFGQRDRSSSA PNVHINTIEPVN IDDLIRDQGF RGDGGSTTGL SATPPASLPG 
SLTNVKALQKS PGPQRERKSSSS SEDRNRMKTLGR RDSSDDWEIPDG 
Q|ITVGQRIG SGSFGTVYKG KWHGDVAVKM LNVTAPTPQQLQ 
AFKNEVGVLR KTRHVNILLF MGYSTKPQLAI VTQWCEGSSLY HHLHIIETKFE 
MIKLIDIARQT AQGMDYLHAKSI IHRDLKSNNI FLHEDLTVKIG DFGLATVKSR 
WSGSHQFEQL SGSILWMAPE VIRMQDKNPY SFQSDVYAFG IVLYELMTGQ 
LPYSNINNRDQ IIFMVGRGYL SPDLSKVRSN CPKAMKRLMA ECLKKKRDERP 
LFPQILASIEL L|ARSLPKIH RSASEPSLNRAG FQTEDFSLYAC ASPKTPIQAGGY 
GAFPVH 
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D-Raf sequence (739 aa) 
MSSESSTEGD SDLYDPLAEE LHNVQLVKHV TRENIDALNA KFANLQEPPA 
MYLIEYQELT SKLHELEAKE QELMERLNS|Q DQQEDSSLVE RFKEQPHYQN 
QTQILQQQRQ LAR|VHHGNDL TDSLGSQPGS QCGTLTRQPK| ILLRAHLPNQ 
QRTSVEVISG VRLCDALMKA LKLRQLTPDM CEVSTTHSGR HIIPWHTDIG 
TLHVEEIFVRL L|DKFPIRTHI K|HQIIRKTF FSLVFCEGCR RLLFTGFYCS 
QCNFRFHQRC ANRVPMLCQP F|PMDSYYQLL LAENPDNGVG FPGRGTAVRF 
NM|SRSRSRRCS SSGSSSSSKP PSSSS|GNHRQ GRPPRISQDD RSNSAPNVCI 
NNIRSVTSEV QRSLIMQARP PLPHPCTDHS NSTQASPTST LKHNRPRARS 
ADESNKNLLL RDAKSSEENW NILAEE|ILIG PRIGSGSFGT VYRAHWHGPV 
AVKTLNVKTP SPAQLQAFKN EVAMLKKTRH CNILLFMGCV SKPSLAIVTQ 
WCEGSSLYKH VHVSETKFKL NTLIDIGRQV AQGMDYLHAK NIIHRDLKSN 
NIFLHEDLSV KIGDFGLATA KTRWSGEKQA NQPTGSILWM APEVIRMQEL 
NPYSFQSDVY AFGIVMYELL AECLPYGHIS NKDQILFMVG RGLLRPDMSQ 
VRSDAPQALK RLAEDCIKYTP KDRPLFRPLL NMLENMLRTLP KIHRSASEPNL 
TQSQLQNDEFL YLPSPKTPVNF NNFQFFGSAGNI 
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Minimal media 
The amounts below are for “Full” expression, for “Test” expression use one tenth of 
each. After autoclaving the solution bellow add 4 ml of o/n culture ('Full') or 400 μl 
('Test'). 
 
“5 x salt solution”: 
Material Purpose Amoun
t 
Units
Sodium Phosphate dibasic anhydrose  Na2HPO4  Phosphate source 13.6 gr 
Potassium Phosphate monobasic KH2PO4  Potassium source 6 gr 
Sodium chloride NaCl Sodium source 1 gr 
Ammonium Chloride NH4Cl Nitrogen source 2 gr 
e-pure-H2O Water 400 ml 
 
Dissolve  100 ml of “5 x salt solution” in 400 ml e-pure-H2O (use 2 liter flasks) and 
autoclave. Before inoculation add the “organic solution” to each 2 liter flask (use sterile 
technique).  
 
“organic solution”: 
Material Purpose Amoun
t 
Units
20% w/v sterile filtered (0.2) Glucose carbon source 10 ml 
BME vitamin solution vitamins 5 ml 
½% Thiamine hydrochlorate  vitamin 500 l 
1 M sterile (autoclaved) MgSO4  salt 1 ml 
1 M sterile (filtered) CaCl2  salt 10 l 
Ampicillin (100g/ml) antibiotics 1 ml 
 
 
Resuspension buffer 
1 ml SEC buffer with a dash of Lysozyme [SIGMA, Lysozyme, from chicken egg white, 
44700 units/mg, 5 gr bottle]. 
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SEC buffer 
Adjust pH to 6.0 with NaOH (final volume 4 liter). store in cold room; good for two 
months.  
Material Purpose Amoun
t 
Units
Potassium Phosphate monobasic KH2PO4  buffer 27.22 gr 
Sodium chloride NaCl molarity 17.53 gr 
DTT reducing agent 1.234 gr 
20% Sodium Azide (tri-nitride) NaN3 bacteriocidal 4 ml 
3 M Sodium Hydroxide NaOH adjust pH  ~55 ml 
e-pure-H2O Water 3946 ml 
 
 
Pellet buffer 
100 μl SEC buffer with 1 μl of DNase [SIGMA, D4527-40kU, Deoxyribonuclease I, 
Type II, from Bovine Pancreas]. 
 
Glutathione S-transferase (GST) gene fusion system 
The GST gene fusion system is an integrated system for the expression, purification and 
detection of fusion proteins produced in bacterial, yeast, mammalian and insect cells. 
The sequence encoding the GST protein is incorporated into an expression vector, 
generally upstream of the multi-cloning site. The sequence encoding the protein of 
interest is then cloned into this vector. Induction of the vector results in expression of a 
fusion protein, i.e., the protein of interest fused to the GST protein. The fusion protein 
can then be released from the cells and purified. 
Purification of the fusion protein is facilitated by the affinity of the GST protein for 
glutathione residues. Glutathione residues are coupled to a resin and the expressed 
protein product is brought into contact with the resin. The fusion protein will bind to the 
glutathione-resin complex and all other non-specific proteins can be washed off. The 
fusion protein can then be released from the resin using a mild elution buffer which is of 
low pH or a buffer with the same pH as the protein buffer but with a high concentration 
of glutathione. 
It is possible to remove the GST from the protein of interest by using a number of 
different enzymes (Thrombin, Factor X), which cleave specific sites between the GST 
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and the protein of interest. 
Fusion proteins can also be detected easily, with a number of GST antibodies now 
available on the market. 
Advantages of the GST System: (1) generic tool for protein expression, purification and 
detection - no need to produce individual antibodies to each protein of interest; (2) 
suitable for use in all expression systems: bacterial, yeast, and mammalian; (3) low cost 
of resin, and resin can be regenerated for multiple uses; (4) simple one step purification 
methodology; (5) mild elution conditions; (6) purity of protein is high; (7) GST antibody 
available for detection of fusion protein; and (8) widely used system. 
 
Glutathione-Sepharose 4B technical specifications 
Manufacturer: Amersham Biosciences, catalog# 17-0756-01. Glutathione coupling 
method: Epoxy activation. Binding capacity: > 5 mg horse liver GST/ml medium. 
Matrix: Agarose, 4%; Average particle size: 90 µm. pH stability: 4-13. Storage: 20% 
ethanol (+4-8 °C). 
 
Thrombin solution 
We used 1000 U bottles of lyophilized Thrombin (Bovine) supplied by CALBIOCHEM. 
Resuspend the Thrombin powder by adding 1 ml of fresh SEC buffer per bottle.  
 
D-Raf 160 aa long N-terminal segment sequence as reported by the “Protein Facility” 
(DNA sequencing) 
plasmid pGEX2, contains restriction sites BamH1 and EcoRI. We used for sequencing 8 
μl of 0.25 μg/μl purified plasmid.    
 
DNA sequence 
“NNNNNNNNNNNNNNCNNCGTTTGGTGGTGGCGANCATCCTCCAAAATCGGA
TCTGGTTCCGCGTGGATCCAGCGAGTCCTCCACCGAAGGCGACAGCGATCTA
TACGATCCTTTGGCCGAGGAGCTGCACAACGTCCAGTTGGTCAAACATGTGA
CCCGCGAGAATATTGATGCCCTGAATGCCAAGTTTGCCAACCTGCAGGAGCC
ACCAGCCATGTACTTAATAGGTGAGTCGTCGAAAGCCGAGCTGAACACTACC
TGGGTTCTTGGAAATCCCACGCCCACCTCCAAGCTATTTATAAAATACCCGAC
61 
ATATGTGTATGTATGTATCTCACGACTTTGGTTCTTGCCCACAGAATACCAGG
AGTTGACCTCCAAGCTCCACGAACTGGAGGCCAAGGAGCAGGAACTAATGG
AGCGACTGAACTCGCAGGACCAGCAGGAGGACTCCTCCTTGGTCGAGCGGTT
CAAGGAGCAGCCCCACTATCAAAATCAAACTCAAATCCTGCAGCAACAACGG
CAATTGGCGCGAATTCATCGTGACTGACTGACGATCTGCCTCGCGCGTTTCGG
TGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCT
TGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCG
GGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCG
GANTGTATAATTCTTGAAGACGAAAGGGNCTCGTGATACGCCTATTTTTATAG
GTTAATGTCATGATAATAATGGNTTCTTAGACGTCNNNTNNNCTTTTCGGGGA
AATGTN” 
 
 
Translated protein sequence 
GST C-terminal containing Gly-linker and Thrombin cleavage site:  
“FGGGXHPPKSDLVPR “ 
D-Raf 160 aa long N-terminal segment that is fused to the GST:  
“GSSESSTEGD  SDLYDPLAEE  LHNVQLVKHV  TRENIDALNA  KFANLQEPPA  
MYLIGESSKA  ELNTTWVLGN  PTPTSKLFIK  YPTYVYVCIS  RLWFLPTEYQ   
ELTSKLHELE  AKEQELMERL  NSQDQQEDSS  LVERFKEQPH  YQNQTQILQQ  
QRQLARIHRD” 
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Script of the nmrPipe program for processing the 2D 15N-HSQC experimental data  
 
(*) the program has only 14 lines. 
 
1:#!/bin/csh 
2:nmrPipe -in test.fid                                                   \ 
3:| nmrPipe -fn SP -off 0.49 -end 0.99 -pow 1 -c 0.5   \ 
4:| nmrPipe -fn ZF -auto                                               \ 
5:| nmrPipe -fn FT -auto                                               \ 
6:| nmrPipe -fn PS -p0 -90.0 -p1 90.0  -di -verb           \ 
7:| nmrPipe -fn TP                                                        \ 
8:| nmrPipe -fn SP -off 0.49 -end 0.99 -pow 1 -c 0.5   \ 
9:| nmrPipe -fn ZF -auto                                              \ 
10:| nmrPipe -fn FT -auto                                              \ 
11:| nmrPipe -fn PS -p0 90.0 -p1 0.0 -di -verb              \ 
12:| nmrPipe -fn TP                                                      \ 
13:| nmrPipe -fn POLY -auto                                        \ 
14:| pipe2xyz -out end_HSQC_x_m90_90_y_90_0_POLY.nv -nv 
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Script of the nmrPipe program for processing the 3D 1H,15N-TOCSY and 3D 1H,15N-
NOESY HSQC experimental data 
(*) The program has only 61 lines: 
1:#!/bin/csh 
2: 
3:if ($#argv != 1) then 
4:  echo Usage: $0 root_name 
5:else 
6: 
7:xyz2pipe -in $1%03d.fid -x -verb                          \ 
8:| nmrPipe -fn SOL -mode 1 -fs 3                           \ 
9:| nmrPipe -fn SP -off 0.5 -end 0.99 -pow 2 -c 0.5  \ 
10:| nmrPipe -fn ZF -auto                                           \ 
11:| nmrPipe -fn FT -auto                                           \ 
12:| nmrPipe -fn PS -p0 -20 -p1 0 -di                         \ 
13:| nmrPipe -fn EXT -left -sw                                   \ 
14:| pipe2xyz -out $1%03d.ft1 -x 
15: 
16:xyz2pipe -in $1%03d.ft1 -y -verb                          \ 
17:| nmrPipe -fn SP -off 0.5 -end 0.99 -pow 2 -c 1.0  \ 
18:| nmrPipe -fn ZF -auto                                           \ 
19:| nmrPipe -fn FT -auto                                           \ 
20:| nmrPipe -fn PS -p0 90 -p1 180 -di                       \ 
21:| pipe2xyz -out $1%03d.ft2 -y 
22: 
23:rm $1*.ft1 
24: 
25:xyz2pipe -in $1%03d.ft2 -z -verb                          \ 
26:| nmrPipe -fn SP -off 0.5 -end 0.99 -pow 2 -c 1.0  \ 
27:| nmrPipe -fn ZF -auto                                            \ 
28:| nmrPipe -fn FT -auto                                            \ 
29:| nmrPipe -fn PS -p0 90 -p1 180 -di                       \ 
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30:#| nmrPipe -fn REV                                                \ 
31:| pipe2xyz -out $1%03d.ft3 -z 
32: 
33:rm $1*.ft2 
34: 
35:xyz2pipe -in $1%03d.ft3 -z -verb                   \ 
36:| nmrPipe -fn HT -auto                                    \ 
37:| nmrPipe -fn PS -inv -hdr                                \ 
38:| nmrPipe -fn FT -inv                                       \ 
39:| nmrPipe -fn ZF -inv                                       \ 
40:| nmrPipe -fn SP -inv -hdr                                \ 
41:| nmrPipe -fn LP -auto                                      \ 
42:| nmrPipe -fn SP -hdr                                        \ 
43:| nmrPipe -fn ZF -auto                                      \ 
44:| nmrPipe -fn FT -auto                                      \ 
45:| nmrPipe -fn PS -hdr -di                                  \ 
46:| pipe2xyz -out $1%03d.ft4 -z 
47: 
48:rm $1*.ft3 
49: 
50:xyz2pipe -in $1%03d.ft4 -x -verb                   \ 
51:| nmrPipe -fn POLY -auto                               \ 
52:| pipe2xyz -out $1%03d.ft5 -x 
53: 
54:rm $1*.ft4 
55: 
56:xyz2pipe -in $1%03d.ft5 -x -verb                   \ 
57:| nmrPipe -fn NULL                                       \ 
58:| pipe2xyz -out NOESY_x_m20_0_y_90_180_z_90_180_linear_prediction_poly.nv 
59:-nv 
60: 
61:endif 
65 
Script written in Tcl/Tk for choosing only high intensity and wide-area peaks for 
preparing of peak-lists in nmrViewJ 
 
(*) Execute in nvj by typing in the “swkcon 2.4 Main” window:  
>     /home/toren/nmr/D_RAF/031307_draf_117aa_wt_collection_of_data/peaklistsift.tcl 
>     peaklistsift 
 
(*) The program (has only 23 lines): 
1:# Purpose: sifts a peak list called "toc" from peaks whose area is smaller than a value 
set 2:#by the variable "minarea" 
3: 
4: proc peakslistsift args 
5:{ 
6: 
7:set plist toc 
8:set minarea 15 
9:set peaklist $plist   
10:   
11:foreachpeak peak $peaklist 
12:{ 
13:         
14:  set area [expr [nv_peak elem 1H.W $peaklist.$peak]*[nv_peak elem HN.W 
 15:     $peaklist.$peak]*10000] 
16:                    if {$area<$minarea} 
17:{ 
18:     nv_peak delete $peaklist.$peak 
19:     puts $peaklist.$peak 
20:     puts $area 
21:}   
22:} 
23:} 
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